Document:

Exhibit 10.1

 

Employment Agreement

Duly made and executed on the date set forth in Appendix 1

By and Between

Advanced Inhalation Therapies (AIT) Ltd.

 (hereinafter the "Company")

and

Hai Aviv

(hereinafter the "Employee")

(other details as set forth in Appendix 1)

WHEREAS The Company desires to employ the Employee on the terms and conditions set forth herein and the Employee desires to enter into this Agreement on such terms and conditions; and

WHEREAS The Employee represents that, he has the requisite skills and training to fulfill his obligations as set forth herein;

NOW, THEREFORE, in consideration of the undertakings of the parties, it is hereby agreed:

 

	1.	
DUTIES AND RESPONSIBILITIES

 

		1.1.	
Position. The Employee shall serve in the position set forth in Appendix 1 hereto, and shall report to his direct manager set forth in Appendix 1, or to any other person, as the Company, at its sole discretion, shall instruct the Employee from time to time.

		1.2.	
Exclusivity. unless Company agrees otherwise (in advance and in writing), the Employee (i) shall devote his full working time (as defined herein), attention, energies, skills, knowledge and experience to the faithful, responsible, competent, diligent, and conscientious performance of his duties and responsibilities hereunder and best efforts to the business and affairs of the company; (ii) shall not engage in or be associated with, directly or indirectly, any business which is competitive, directly or indirectly, with the business of the Company, as more fully described in Appendix 2 attached hereto; and (iii) shall not undertake or accept any other paid or unpaid employment or occupation.

		1.3.	
Traveling. The Employee's employment may require travel outside Israel and the Employee agrees to such travel as may be necessary in order to fulfill his duties hereunder.  The employee shall engage in such travel as may reasonably be required in connection with the performance of his duties. All reasonable travel and other expenses incurred by the employee (in accordance with the policies as established from time to time) in carrying out his duties hereunder will be reimbursed by the Company on presentation to it of expense accounts and appropriate documentation in accordance with the customary procedures of the Company for reimbursement of employee expenses.

		1.4.	
Compliance. Without derogating from the above, the Employee shall act in accordance with the Company's policies, regulations and general instructions as shall be published and updated from time to time, including, but not limited to, the Company's Sexual Harassment Policies. Without derogating from the provisions of Section 2.3 below, in the event of a breach of this Section 1.4 or any of the policies mentioned herein, Company shall have the right to immediately terminate this Agreement without prior notice, based on Company’s sole discretion.

		1.5.	
Exclusivity of Agreement. This Agreement is personal and special, and exclusively defines the entire relationship between the Company and the Employee and all compensation and/or benefits to which the Employee is entitled from the Company. This Agreement supersedes any prior agreements, understandings and arrangements, oral or written, applied, exchanged or signed between the parties hereto with respect to the subject matter hereof. The Employee shall not be entitled to, and shall not demand, any other compensation and/or benefit from the Company, unless explicitly provided for hereunder, and no practice and/or custom existing between the Company and other employees, if any, shall apply to the relationship between the Employee and the Company, unless explicitly incorporated into this Agreement, and then only to the extent so incorporated. This Agreement shall be considered as a notification of the terms of employment as required by law.

 

	2.	
TERM AND TERMINATION

 

		2.1.	
Term of Engagement. This Agreement and the employer-employee relationship created hereunder shall become effective on the date set forth in Appendix 1 (the "Commencement Date"), and will remain in force until terminated by a party at any time by giving a prior written notice of termination or resignation (the “Term”), of a period as set forth in Appendix 1 (the "Notice Period").

		2.2.	
Notice Period. During the Notice Period, the Employee shall continue to provide all services per this Agreement in full and in a proper manner and shall cooperate with the Company and use his best efforts to assist in the integration into the Company's organization of the person or persons who will assume the Employee's responsibilities. Notwithstanding the above, the Company shall be entitled to waive the Employee's services with the Company during the Notice Period or any part thereof and/or terminate the employer-employee relationship prior to the completion of the Notice Period. In such event, the Company shall pay the Employee the amount equal to the compensatory payment as required by the Prior Notice Law, and the Employee shall immediately return to the Company any and all equipment provided to him by the Company (including any car, computer, documents, data, etc.).

		2.3.	
Termination for Justifiable Cause. Notwithstanding the provisions of Sections 2.1 and 2.2 above, the Company shall have the right to terminate this Agreement and the employer-employee relationship hereunder at any time for a Justifiable Cause (as defined below), by giving the Employee a notice of termination for cause.

 

The term "Justifiable Cause" shall mean (a) indictment or conviction of the Employee for committing a crime; or (b) a serious breach of trust including but not limited to theft, fraud, disclosure to unauthorized persons or entities of confidential or proprietary information of the Company and/or the engaging by the Employee in any business competitive to the business of the Company; or (c) any breach of Sections 4 or 5 of this Agreement; or (d) any sexual harassment; or (e) violent behavior; or (f) consistent noncompliance with Company's policies, orders and regulations; or (g) performance, by the Employee, of any act that entitles the Company to dismiss him without paying him any or partial severance pay in connection with such dismissal under applicable law.

 

		2.4.	
Final Settling. At the end of the employer-employee relationship, the Company and the Employee shall conduct a final settling of the Employee's accounts to be held according to the Company's records.  Such settling of accounts shall be final and no party shall have any further claim or demand from the other party. It is agreed that, subject to the applicable laws, the Company shall be entitled to deduct any amount the Employee shall owe the Company at such time from the amounts he shall be entitled to.

		2.5.	
Release of Funds. It is hereby agreed between the parties that at the end of the employment relationship, other than upon termination in circumstances justifying dismissal without any or partial severance pay under applicable law, all sums accumulated in the Employee's Pension Insurance policies (after completion of payment of all premiums previously due with respect to such Pension Insurance Policies), shall be released and transferred to the Employee. The Company and Employee agree and acknowledge that in the event the Company transfers ownership of Employee’s Pension Insurance Policies to the Employee, the severance portion thereof shall constitute full and final payment towards any severance pay the Company may be required to pay to the Employee pursuant to the Severance Pay Law 5727-1963, and that this Section is in accordance with the provisions of Section 14 of the Severance Pay Law 5727-1963, and with the General Approval of the Labor Minister, dated June 30, 1998 (issued in accordance with the said Section 14) a copy of which is attached hereto as Appendix 3.

		2.6.	
Return of Equipment. At the end of the employer-employee relationship the Employee shall return to the Company any and all documents, professional literature, equipment and property belonging to the Company, which may be in Employee's possession at such time. Should the Employee refuse and/or fail to do so, the Company shall have the right, in addition to any other remedy available under any law, to offset the value of such property (as shall be determined solely by the Company) from the amounts (if any) that the Employee might be entitled to.

 

	3.	
GROSS SALARY AND BENEFITS

 

		3.1.	
Gross Salary

		3.1.1.	
GENERAL. The Company shall pay the Employee a gross monthly salary in the amount set forth in appendix 1 (the "Gross Salary"). As detailed below, the Gross Salary is inclusive of overtime payment and special non-competition monthly compensation (as such terms are defined below).The Gross Salary shall be updated according to the increases determined by applicable law ("Tosefet Yoker" or similar provisions).

 

The Gross Salary shall be comprehensive and all-inclusive and it shall be deemed to embody any and all compensation the Employee shall be entitled to in connection with his employment by the Company.

 

		3.1.2.	
Payment. The Gross Salary for each month shall be payable until the 9th calendar day of the following calendar month.

		3.1.3.	
NO APPLICATION OF WORK AND REST LAW. Since the Employee is employed hereunder in a managerial position and/or in a position involving a special fiduciary relationship between the Employee and the Company, the Work and Rest Law (5711-1951), and any other law amending or replacing such law, shall not apply to the employee or to his employment with the Company, and the Employee shall not be entitled to any compensation in respect of such law. The Employee acknowledges that the compensation set forth in this Agreement includes any compensation otherwise due to the Employee pursuant to such law. The Employee undertakes, that he will not sue, and/or demand, and/or claim that he is entitled to any additional payment to his Gross Salary due to overtime, above his Gross Salary which includes all the consideration which the Employee is entitled to receive for overtime.

		3.1.4.	
Global Payment for Over-time. Without derogating from the above, it is expressly agreed that an amount equal to 30% of the Gross Salary shall be paid to the Employee on account of overtime hours ("Shaot Nosafot") as a global payment in consideration for overtime work and work during weekly rest or on holidays, whether actually performed by the Employee or not. For the purpose of this Agreement, the payments made in consideration of the overtime hours shall be referred to as "Overtime Payment".

		3.1.5.	
Occasional Benefits. Any benefit, of any kind, granted to the Employee by the Company and which is not specified in this Agreement (a "Benefit"), shall be deemed as a non-recurring event, and shall neither give rise to any new right of the Employee, nor constitute a practice and/or custom and/or precedent between the parties which shall obligate the Company on any additional and/or other occasions. It is hereby agreed, that any such Benefit shall be a supplement above and beyond the Employee's Gross Salary, and shall not to be taken into account for the purpose of calculating the Employee's social entitlements or rights.

		3.1.6.	
Tax Deductions. The Company shall legally deduct and withhold income tax payments and any other obligatory payments, such as social security and health insurance, from all the payments, which shall be paid to the Employee in accordance with this Agreement and as required by law at such time.

		3.2.	
Non-Competition Compensation. The Employee acknowledges that an amount equal to 10% of the Gross Salary is paid to him as a special supplementary monthly compensation in consideration for the Employee's obligation not to perform any Competitive Activity (as stated in Section 4 to Appendix 2 hereto; the "Special Non-Competition Compensation"). The specific amount of Non-Competition Compensation (which may be updated pursuant to any change in the Gross Salary amount) is detailed in Appendix 1. The Employee warrants and represents that the Special Non-Competition Compensation amount constitutes real, appropriate and full compensation for any prejudice he may suffer due to his obligation not to engage with any competitive activity, including but not limited to restriction of his freedom of employment.

		3.3.	
Recuperation Pay. The Employee shall be entitled to Recuperation Pay ("Dmey Havra'a") in accordance with the applicable law.

		3.4.	
Vacation. The Employee shall be entitled to the number of work days' vacation in each calendar year, as set forth in Appendix 1. The Employee is obligated to use at least seven (7) consecutive vacation days during each calendar year, commencing  on the Commencement Date (as defined in Appendix 1) and during each calendar year thereafter. To the extent permitted by law, unused vacation days may be carried forward from one calendar year to the next.  Any vacation days that are unused within two (2) years following the year in which they were accumulated, shall expire.

		3.5.	
Sick Leave. The Employee shall be entitled to paid sick leave according to the law or in accordance with the Company’s policies, as amended from time to time.

 

		3.6.	
Pension Insurance.

 

The Company and the Employee will obtain and maintain Managers Insurance and/or a comprehensive Pension Fund according to the Employee's choice ("Pension Insurance"). The Employee is entitled to receive the Company’s contribution for his Pension Insurance Policies (Pension Funds and/or Managers Insurance) from the date indicated in Appendix 1:

 

		3.6.1.	
The Company shall affect a Pension Insurance Policy (the "Policy") for the Employee, and shall pay the percentages detailed in Appendix 1 towards such Policy, on account of severance pay and Tagmulim.

		3.6.2.	
The Company shall make additional payments, as detailed in Appendix 1, on account of disability insurance, in accordance with Company’s policies.

		3.6.3.	
Unless otherwise is indicated in Appendix 1, the Company shall deduct the percentage set forth in Appendix 1 from the Gross Salary for Pension Insurance to be paid on behalf of the Employee towards such Policy.

 

It is clarified that the Employee shall bear any and all taxes, which may apply with respect to any contribution, which exceeds the recognized tax ceilings with respect to the Pension Insurance.

		3.7.	
Education Fund. The Employee is entitled to Education Fund payments from the date indicated in Appendix 1 (if at all) as follows:

		3.7.1.	
The Company shall pay a sum equal to a percentage that is detailed in Appendix 1 of the Maximum Salary for Education Fund and (ii) shall deduct a percentage that is detailed in Appendix 1 from the Maximum Salary for Education Fund to be paid on behalf of the Employee toward a further education fund. Use of this fund shall be in accordance with the policies of the relevant fund.

		3.7.2.	
The term "Maximum Salary for Education Fund" as used herein shall mean an amount equal to the lower of (i) the Gross Salary of the Employee, or (ii) the highest amount recognized by the Israeli Tax Authorities for income tax exemption regarding education fund payments.

		3.8.	
Military Reserve Duty. Employee shall inform the company of any military reserve duty employee has been ordered to perform, immediately after he/she has been notified of the same. Employee undertakes to provide company with proper confirmation of active military reserve duty, so that company may collect from the national insurance institute all amounts to which employee or company is entitled in connection with such service.

 

		3.9.	
CAR LEASING.

If stated in Appendix 1 that the Employee is entitled to join the Company's car leasing program, the Company shall deduct the required amounts associated with the leasing and the use of a leased car (the “Leasing Car”) from the Employees Gross Salary. The Employee shall be liable for any income tax liability applicable to his use of the Leasing Car (in addition to bearing the usage cost as mentioned above). It is further clarified that the deduction of the usage cost of the Leasing Car will also reduce the Gross Salary for calculating the social benefits that the Employee is entitled to.

The use of the Leasing Car shall be in accordance with the relevant policies and regulations of the Company and according to the terms and conditions as determined by the leasing company. If required by the Company, the employee will execute additional documents with respect to the use of the Leasing Car, including without limitation, the applicable leasing agreement between the Employee and the applicable leasing company indicated by the Company at such time.

 

		3.10.	Cellular Phone. If indicated in Appendix 1 the Employee will be entitled to a cellular phone (the "Cellular Phone"), as of the Commencement Date. The use of the Cellular Phone, including the type of the Cellular Phone, will be as indicated in the Company’s Cellular Phone Policy, as amended from time to time. The limitations on use and coverage of any expenses related to the Cellular Phone will be indicated in the Cell Phone Policy, as amended from time to time, but in any event, the Employee will be solely responsible for any communication or issue with the applicable cellular operator related to the Cellular Phone. For the avoidance of doubt, the Employee will bear any and all taxes applicable to the Employee in connection with the Cellular Phone use thereof.

In event the Cellular Phone number is registered with the cellular service company in the name of the Company, upon the Company's first demand, the Employee shall immediately transfer the Cellular Phone on his name.

 

	4.	
PROPRIETARY INFORMATION AND WORK PRODUCT; EQUIPMENT

 

		4.1.	
Confidentiality to Terms. The Employee agrees to keep all the terms and conditions of this Agreement in strict confidence and not to disclose them to any person without the prior written consent of the Company unless as required by the relevant laws and regulations.

		4.2.	
Non-Disclosure and Non-Competition Agreement. Concurrently with the execution of this Agreement, the Employee is executing the Non-Disclosure and Non-Competition Agreement, which is attached hereto as Appendix 2, and which is an integral part hereof.

		4.3.	
Monitoring of Systems. The Company's Systems (as defined below) or access which is provided to the Employee are and shall remain the sole property of the Company. The Employee shall use such Systems for business purposes only. To ensure the security of such Systems and to protect the Company's confidential and proprietary information, the Company reserves the right, and the Employee hereby agrees that the Company and anyone on its behalf may, at any time and for any purpose, monitor the Employee's use of the Systems and monitor, copy, transfer and disclose all electronic communications and content transmitted by or stored in such Systems, regardless of the location, time or purpose of such use (other than protected private use in accordance to law).  For the purposes of this Section 4.3, "Systems" include any equipment and software of any kind, including Employee's computer, Company's mailbox, Company's and/or Employee's telephone, etc. Employee acknowledges and approves that the provisions of this Section 4.3 are reasonable in light of the Employee's position with the Company, in the course of which the Employee has and shall gain broad knowledge of the Company's Proprietary Information.

		4.4.	
Survival. Sections 4 above will remain in full force and effect after termination of this Agreement.

 

	5.	
WARRANTIES

 

		5.1.	
The Employee has the knowledge, abilities and skills required to perform the duties of his position.

		5.2.	
The Employee shall inform the Company, immediately upon becoming aware of any matter in which he or a member of his immediate family or affiliate has a personal interest or which might create a conflict of interests with his duties under this Agreement.

		5.3.	
In carrying out his duties under this Agreement, the Employee shall not make any representations, or give any guaranties on behalf of the Company, except as authorized to do.

		5.4.	
The Employee represents and warrants that on the date hereof he is free to provide services to the Company upon the terms contained in this Agreement and that there are no employment contracts, consulting contracts or restrictive covenants preventing full performance of his duties hereunder.

		5.5.	
The Employee represents and warrants that he will not use during the course of his employment with the Company any trade secrets or proprietary information that is the property of his previous employer(s) in such a manner that may breach any confidentiality or noncompetition agreement or other obligation the Employee may have with such former employer(s).

 

	6.	
GENERAL PROVISIONS

 

		6.1.	
In this Agreement words importing the masculine gender shall include the feminine gender.

		6.2.	
This Agreement shall not be amended, modified or varied by any oral agreement or representation or otherwise than by written instrument executed by either parties or their duly authorized representatives.

		6.3.	
This Agreement is personal to the Employee, and the Employee shall not assign or delegate his rights or duties to a third party, whether by contract, will or operation of law, without the Company's prior written consent.

		6.4.	
This Agreement shall inure to the benefit of the Company's successors and assigns.

		6.5.	
Each notice and/or demand given by one party pursuant to this Agreement shall be given in writing and shall be sent by registered mail to the other party at the address appearing in the caption of this Agreement, and such notice and/or demand shall be deemed given at the expiration of seven (7) days from the date of mailing by registered mail or immediately if delivered by hand.  Such address shall be effective unless notice of a change in address is provided by registered mail to the other party.

		6.6.	
It is hereby agreed between the parties that the laws of the State of Israel shall apply to this Agreement. The legally authorized courts in the district of Tel Aviv, Israel, shall have exclusive jurisdiction over the parties hereto and subject matter hereof.

		6.7.	
No Waiver. No delay, failure, or forbearance to exercise any right, power, or remedy accruing to either party upon breach or default under this Agreement shall be deemed a waiver of any prior or subsequent breach or default of this Agreement, nor affect the validity of any provision of this Agreement.

		6.8.	
Integration. This Agreement sets forth the entire agreement between the parties on the subject hereof and supersedes any previous oral or written agreements, understandings, memoranda, emails, letters or representations on the subject matter hereof.

		6.9.	
Severance. If any one or more of the terms of this Agreement shall for any reason be held to be invalid or unenforceable, such term shall be construed in a manner to enable it to be enforced to the extent compatible with applicable law. Any determination of the invalidity or unenforceability of any provision of the Agreement shall not affect the remaining provisions hereof unless the business purpose of this Agreement is substantially frustrated thereby.

 

		6.10.	The Company is not a party to any Collective Agreement.

 

		6.11.	The above and the said in the appendixes shall be without prejudice to any right conferred to the Employee by any law, Extension Order or Collective Agreement.

IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first above written:

 

 

	
/s/ Amir Avniel, CEO 

	 	
/s/ Hai Aviv 

	
Advanced Inhalation Therapies (AIT) Ltd.

 	 	
Hai Aviv

 
	Date:	
1/26/2017

	 	 	Date:	
1/25/2017

	 

Appendix 1

	
1

	
Employee Personal Details

	
Full Name: Hai Aviv

I.D. Number:  040797805

Date of Birth: August 10, 1981

Address: 15 Yeshayahu St., Tel Aviv.

Cellphone Number: 972-54-4736596

	
2

	
Position in the Company

Direct manager

	
Chief Financial Officer and Head of Israel

CEO or USA based CFO if appointed.

	
3

	
Commencement Date

	
February 28, 2017

	
4

	
Period of prior notice (mutual):

	
90 days.

	
5

	
Gross Salary:

	
 

	 	
- Main salary sum:

	 NIS 21,000 NIS
	 	
-Global payment for Overtime (represent 55.5 overtime hours per month)

	
NIS 10,500 NIS

	 	
-Special Non-Competition Monthly Compensation

	
NIS 3,500 NIS

	 	
Total

	
NIS 35,000

	
6

	
Yearly Vacation Days

	
 20 Days

	
7

	
Pension Insurance

	
Entitled as of the Commencement Date

	
Ø          For severance pay

	
8.33 % of Gross Salary

	
Ø          For Tagmulim

	
6.5 % of Gross Salary for Pension Fund

Gross Salary for Mangers Insurance (combined with work disability)

6.5%.

	
Ø          For disability pension

	
Not more than 2.5 % of Gross Salary but in accordance with the applicable plan that was selected by the Company.

	 	
Ø          Deduct from Employee (on account of 

             Tagmulim)

	
6 % of Gross Salary for Manager’s Insurance or Pension Fund

 

	
8

	
Education Fund

	
Entitled from the Commencement Date

	
Ø          Payment by Company

	
7.5 % of Maximum Salary for Education Fund

	
Ø          Deduct from Employee (on account of 

             education fund)

	
2.5 % of Maximum Salary for Education Fund

	
9

	
Leasing Car

	
Entitled, subject to engagement with the applicable leasing company and according the Company Car Policy.

	
10

	
Commuting Expenses

	
Entitled (according to the Israeli law and the Company’s policy) provided that Employee does not have Leasing Car.

	
11

	
Cellular Telephone

	
In accordance with company policy

	
12

	
Options

	
Subject to the approval of the Board of Directors of AIT Therapeutics Inc. ("Parent"), along with any other corporate or regulatory approvals required, and the adoption of an equity compensation plan by the Parent (the "Plan"), the Parent will issue to the Employee options to purchase 50,000 shares of common stock of the Company.  The terms of the grant shall be as determined by the Board of Parent and the terms of the Plan.  

 

 

	
/s/ Amir Avniel, CEO 

	 	
/s/ Hai Aviv 

	
Advanced Inhalation Therapies (AIT) Ltd.

 	 	
Hai Aviv

 
	Date:	
1/26/2017

	 	 	Date:	
1/25/2017

	 

Appendix 2

 

Non-Disclosure and Non-Competition Agreement

I acknowledge that as a result of my employment by Advanced Inhalation Therapies (AIT) Ltd. (the "Company"), I may develop, receive, or otherwise have access to confidential or proprietary information that is of value to the Company. I therefore agree, as a condition of my employment, as follows:

 

	1.	
NON - DISCLOSURE

 

		1.1.	
Recognition of Company's Rights; Non - disclosure.  At all times during my employment and thereafter, I will hold in strictest confidence and will not disclose, disseminate, use, copy, lecture upon or publish in any manner or fashion whatsoever, any of the Company's Proprietary Information (as such term is defined below), except as such disclosure, use or publication may be required in connection with my work for the Company, or unless an officer of the Company expressly authorizes such in writing in advance. I will obtain the Company's written approval before publishing or submitting for publication any material (written, verbal, or otherwise) that relates to my work at the Company and/or incorporates any Proprietary Information. I hereby assign to the Company any rights I may have or acquire in such Proprietary Information and recognize that all Proprietary Information shall be the sole property of the Company and its assigns.

		1.2.	
Proprietary Information.  The term "Proprietary Information" shall mean any and all confidential and/or proprietary knowledge, data or information of the Company.  By way of illustration but not limitation, "Proprietary Information" includes (a) trade secrets, inventions, pending patents, mask works, ideas, processes, formulas, source and object codes, data, programs, other works of authorship, know-how, improvements, inventions, discoveries, developments, designs and techniques (excluding inventions that are not assignable under Section 2.4, hereinafter collectively referred to as "Inventions"); and (b) information regarding plans for research, development, new products, marketing and selling, business plans, budgets and any unpublished financial statements and/or information, licenses, strategies, forecasts and projections, prices and costs, suppliers and customers; (c) information regarding the skills and compensation of other employees, management or other personnel of the Company; and (d) information that is disclosed in the furtherance of the business of the Company including, without limitation, the area of activity in which the Company is involved, the Company’s technical, business and financial information, documentation, records, files, memoranda, reports, drawings, plans, price lists, customer lists, and the like. Notwithstanding the foregoing, it is understood that, at all such times, I am free to use information which is generally known in the trade or industry, which is not gained as result of a breach of this Agreement, to whatever extent and in whichever way I wish.

		1.3.	
Third Party Information.  I understand, in addition, that the Company has received and in the future will receive from third parties confidential or proprietary information ("Third Party Information") subject to a duty on the Company's part to maintain the confidentiality of such information and to use it only for certain limited purposes.  During the term of my employment and thereafter, I will hold Third Party Information in the strictest confidence and will not disclose to anyone (other than Company personnel who need to know such information in connection with their work for the Company) or use, except in connection with my work for the Company, Third Party Information unless expressly authorized by an officer of the Company in writing.

		1.4.	
No Improper Use of Information of Prior Employers and Others. During my employment with the Company, I will not improperly use or disclose any Proprietary Information and/or confidential information or trade secrets, if any, of any former employer or any other person to whom I have an obligation of confidentiality, and I will not bring onto the premises of the Company any unpublished documents or any property belonging to any former employer or any other person to whom I have an obligation of confidentiality unless consented to in writing by that former employer or person.

 

	2.	
ASSIGNMENT OF INVENTIONS

 

		2.1.	
Proprietary Rights.  The term "Proprietary Rights" shall mean all trade secret, patent, copyright, mask work and other intellectual property rights throughout the world.

		2.2.	
Prior Inventions.  I hereby confirm that I have transferred and assigned in whole to the Company any and all of my rights, title and interest in any and all Inventions, which are currently being used or contemplated to be used by the Company on the date hereof.  Notwithstanding the foregoing, other than inventions referred to in the immediately preceding sentence, inventions, if any, patented or unpatented, which I made prior to the commencement of my employment with the Company ("Prior Inventions") are excluded from the scope of this Agreement.  If, in the course of my employment with the Company, I incorporate a Prior Invention into a Company product, process or machine, the Company is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, unlimited worldwide license (with rights to sublicense through multiple tiers of sublicenses) to make, have made, modify, use and/or sell and/or otherwise use as the Company may wish, such Prior Invention. Without derogating from the foregoing, I agree that I will not incorporate, or permit to be incorporated, Prior Inventions in any Company Inventions without the Company's prior written consent.

Prior Inventions: _________ [Please List all Prior Inventions (if any)]

		2.3.	
Assignment of Inventions. I will promptly disclose to the Company, or any persons designated by it, all Inventions made or conceived or reduced to practice or learned by me, either alone or jointly with others, during the employment term, as a result of tasks assigned by the Company or as a result of the use of premises and/or equipment owned, leased, or contracted for by the Company.  Furthermore, subject to Section 2.4, I hereby assign and agree to assign in the future (when any such Inventions or Proprietary Rights are first reduced to practice or first fixed in a tangible medium, as applicable) to the Company all my right, title and interest in and to any and all Inventions (and all Proprietary Rights with respect thereto) whether or not patentable or registrable under copyright or similar statutes, made or conceived or reduced to practice or learned by me, either alone or jointly with others, during the period of my employment with the Company and which are connected and/or related to the Company's business and which have been created or developed as part of my work for the Company. Inventions assigned to the Company, or to a third party as directed by the Company pursuant to this Section 2, are hereinafter referred to as "Company Inventions".

		2.4.	
Government or Third Party.  I also agree to assign all my right, title and interest in and to any particular Company Invention to any third party, including without limitation government agency, as directed by the Company.

		2.5.	
Works made for Hire. I further acknowledge that all original works of authorship which are made by me (solely or jointly with others) within the scope of and during my employment with the Company are “works made for hire” as contemplated under Chapter H of the Patents Law of 1967 (the “Patents Law”), that all such “works made for hire” are owned by the Company, its successors, assigns or nominees, and that I shall not be entitled to any compensation, other than the Gross Salary, for creation or assignment of the same to the Company, its successors, assigns or nominees; it being acknowledged and agreed that the Gross Salary and all  other employment terms under the Employment Agreement shall constitute the sole consideration and remuneration for any Inventions, including, without limitation, “works made for hire”, regardless of the current or future value of the Invention. I understand and agree that the decision whether or not to commercialize or market any invention developed by me (including the Inventions), solely or jointly with others, is within the Company’s sole and unfettered discretion and for the Company’s sole benefit and that no royalty will be due to me as a result of the Company’s efforts to commercialize or market any such invention (including the Inventions). This Section 2.5 shall be deemed as an “agreement” for purposes of Section 134 of the Patents Law.

		2.6.	
I acknowledge and agree that in event that, notwithstanding the agreement stipulated herein, it will be decided by a competent authority, court or any other competent tribunal, either due to my application or any other source, that I may deserve additional compensation for Company Inventions, in addition to any amounts paid to me by the Company under and according to my employment agreement (a "Claim"), my Gross Salary (as defined in the Agreement) shall be reduced, retroactively effective as of the date of the beginning of my employment by the Company to an amount equal to 80% (eighty percent) of the Gross Salary actually paid to me by the Company (the “Agreed Alternative Payment”) and I shall be obligated to return to the Company, on the day the Claim was made and/or the demand which contradicts this Agreement was made, all additional amounts that I received from the Company beyond the Agreed Alternative Payment, retroactively from my employment Start Date onward (the “Excess Amount”), plus interest as of the original date of payment thereof. I acknowledge that the Company shall be entitled to set off such Excess Amounts against all amounts that I shall be entitled to under the Agreement, or under the decision of the Court or of any other competent tribunal or authority. Such set-off shall not derogate from the Company's right to collect any additional amounts from me.

In addition, I undertake, by signing this Agreement that I will not, directly or indirectly, make a claim and /or sue and/or demand, from the Company and/or any of its officers, employees and shareholders any additional compensation for creation or assignment of Inventions beyond the amounts paid to me by the Company according to my Employment Agreement.

		2.7.	
Copyright Works. Without derogating from the forgoing, I acknowledge that all original works of authorship which are made by me (solely or jointly with others) within the scope of my employment and which are protectable by copyright are the property of the Company pursuant to applicable copyright law.

		2.8.	
Enforcement of Proprietary Rights. I will assist the Company in every proper way to obtain, and from time to time enforce, any Proprietary Rights relating to Company Inventions in any and all countries. To that end I will execute, verify and deliver such documents and perform such other acts (including appearances as a witness) as the Company may reasonably request for use in applying for, obtaining, perfecting, evidencing, sustaining and enforcing such Proprietary Rights and the assignment thereof.  In addition, I will execute, verify and deliver assignments of such Proprietary Rights to the Company or its designee. My obligation to assist the Company with respect to Proprietary Rights relating to such Company Inventions in any and all countries shall continue beyond the termination of my employment, but the Company shall compensate me at a reasonable rate, to be discussed with the Company, after my termination for the time actually spent by me at the Company's request on such assistance, subject to my consent, which will not be withheld for unreasonable reasons.

		2.9.	
Power of Attorney.  In the event the Company is unable for any reason, after reasonable effort, to secure my signature on any document needed in connection with the actions specified in Section 2.8 hereof, I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent and attorney in fact, which appointment is coupled with an interest, to act for and in my behalf to execute, verify and file any such documents and to do all other lawfully permitted acts to further the purposes of the preceding paragraph with the same legal force and effect as if executed by me.  I hereby waive and quitclaim to the Company any and all claims, of any nature whatsoever, which I now or may hereafter have for infringement of any Proprietary Rights assigned hereunder to the Company.

 

	3.	
RECORDS

 

I agree to keep and maintain adequate and current records (in the form of notes, sketches, drawings and in any other form that may be required by the Company) of all Proprietary Information developed by me and all Inventions made by me during the period of my employment at the Company, which records shall be available to and remain the sole property of the Company at all times.

 

	4.	
COMPETITIVE ACTIVITIES

 

I acknowledge that I have carefully reviewed the provisions of this Agreement, the Employment Agreement and the appendices thereof, fully understand the consequences thereof, and have assessed the respective advantages and disadvantages to me in entering into this Agreement. In light of the aforesaid, I agree that, during the period of my employment by the Company and for a period of one (1) year thereafter, I will not, directly or indirectly, carry on or engage in any employment or business activity, or hold an interest in any business, either as an employee, owner, partner, agent, shareholder, director, consultant or otherwise, which is competitive with the business of the Company ("Competitive Activity"). I agree further that for the period of my employment by the Company and for a period of one (1) year thereafter, I will not induce, solicit, employ or entice away or endeavor to solicit, employ or entice away any employee of the Company to leave the employ of the Company or to perform any Competitive Activity. In addition, I agree not to solicit, canvass or approach or endeavor to solicit, canvass or approach any person who was provided with services by the Company or its subsidiaries, or has provided services to the Company or its subsidiaries, at any time during the twelve (12) months immediately prior to the termination date of this Agreement, for the purpose of offering services which are competitive with those provided by the Company. I acknowledge that due to my position, the Proprietary Information I am and shall be exposed to and the nature of the business of the Company - any Competitive Activity performed by me will severely harm the legitimate rights and interests of the Company, including but not limited to its Proprietary Rights. In light of all the foregoing I acknowledge that this non-competition undertaking is reasonable, proportional and does not exceed the minimum required to protect the Company's legitimate rights and interests. I warrant and represent that the Special Non-Compensation Monthly Compensation (as such term is defined in the Employment Agreement) constitutes a real, appropriate and full consideration to any prejudice I may suffer due to my undertaking not to engage with any Competitive Activity, including but not limited to any restriction to my freedom of employment.

 

	5.	
NO CONFLICTING OBLIGATION

 

I represent that my performance of all the terms of this Agreement and as an employee of the Company does not and will not breach any agreement to keep in confidence information acquired by me in confidence or in trust prior to my employment by the Company. I have not entered into, and I agree not to enter into, any agreement, written or oral in conflict herewith.

 

	6.	
RETURN OF COMPANY DOCUMENTS

 

When I leave the employ of the Company, I will deliver to the Company any and all drawings, notes, memoranda, specifications, devices, formulas, and documents, together with all copies thereof, and any other material containing or disclosing any Company Inventions, Third Party Information or Proprietary Information of the Company.

 

	7.	
NOTIFICATION OF NEW EMPLOYER

 

In the event that I leave the employ of the Company, I hereby consent to the notification of my new employer of my rights and obligations under this Agreement.

 

	8.	
GENERAL PROVISIONS

 

		8.1.	
Severability. I acknowledge that the provisions of this Agreement serve as an integral part of the terms of my employment and reflect the reasonable requirements of the Company in order to protect its legitimate interests with respect to the subject matter hereof. In case any one or more of the provisions contained in this Agreement shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the other provisions of this Agreement, and this Agreement shall be construed as if such invalid, illegal or unenforceable provision had never been contained herein. If moreover, any one or more of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed by limiting and reducing it, so as to be enforceable to the extent compatible with the applicable law as it shall then appear.

		8.2.	
Successors and Assigns. This Agreement will be binding upon my heirs, executors, administrators and other legal representatives and will be for the benefit of the Company, its successors, and its assigns.

		8.3.	
Survival. The provisions of this Agreement shall survive the termination of my employment and the assignment of this Agreement by the Company to any successor in interest or other assignee.

		8.4.	
Waiver.  No waiver by the Company of any breach of this Agreement shall be a waiver of any preceding or succeeding breach.  No waiver by the Company of any right under this Agreement shall be construed as a waiver of any other right.  The Company shall not be required to give notice to enforce strict adherence to all terms of this Agreement.

		8.5.	
Entire Agreement. The obligations pursuant to Sections 1 and 2 of this Agreement shall apply to any time during which I was previously employed (if at all), am or will be in the future employed, by the Company, including as a consultant if no other agreement governs nondisclosure and assignment of inventions during such period. This Agreement is the final, complete and exclusive agreement of the parties with respect to the subject matter hereof and supersedes and merges all prior discussions or agreements between us with respect to the subject matter hereof. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in writing and signed by the party to be charged. Any subsequent change or changes in my duties, salary or compensation will not affect the validity or scope of this Agreement.

		8.6.	
Governing Law. This Agreement shall be governed by, and construed in accordance with the laws of the State of Israel, without giving effect to the rules respecting conflict-of-law.

		8.7.	
Jurisdiction. The legally authorized courts in the district of Tel Aviv, Israel, shall have exclusive jurisdiction over the parties hereto and subject matter hereof.

 

This Agreement shall be effective as of the date the Employment Agreement of the Employee was made effective.

I HAVE READ THIS AGREEMENT CAREFULLY AND UNDERSTAND ITS TERMS.

ACCEPTED AND AGREED TO:

 

	
/s/ Amir Avniel, CEO

	 	
/s/ Hai Aviv 

	
Advanced Inhalation Therapies (AIT) Ltd.

 	 	
Hai Aviv

 
	Date:	
1/26/2017

	 	 	Date:	
1/25/2017Officers' Certificate of Tech Data Corporation

 Exhibit 4-A 

TECH DATA CORPORATION 

OFFICER’S CERTIFICATE 

January 31, 2017 
 Charles
V. Dannewitz, Executive Vice President, Chief Financial Officer of Tech Data Corporation, a Florida corporation (the “Company”), pursuant to Sections 2.01, 3.01, 3.03 and 16.01 of the Indenture, dated as of January 17,
2017, between the Company and MUFG Union Bank N.A., as Trustee (the “Indenture”), hereby certifies that: 

1.    He has read all provisions in the Indenture relating to conditions precedent to the authentication and delivery of
the Company’s Securities (as defined in the Indenture) and the definitions in the Indenture relating thereto and has made such investigation as he considered necessary in connection with the delivery hereof. 

2.    In his opinion, he has made such examination or investigation as is necessary to enable him to express an informed
opinion as to whether or not provisions in the Indenture relating to conditions precedent to the authentication and delivery of Securities under the Indenture have been complied with. 

3.    In his opinion, such provisions have been complied with. 

4.    Pursuant to the resolutions attached hereto as Annexes A-1 and A-2 adopted by the Board of Directors of the Company on January 17, 2017 and by the Pricing Committee of the Company on January 24, 2017, respectively, the 3.700% Senior Notes due 2022 (the
“2022 Notes”) and the 4.950% Senior Notes due 2027 (the “2027 Notes” and together with the 2022 Notes, the “Notes”) to be issued under the Indenture will have the following terms: 

(a)    The 2022 Notes will be in an initial aggregate principal amount of $500,000,000 and the 2027 Notes will be in an
aggregate principal amount of $500,000,000 and will rank on a pari passu basis with all of our other senior unsecured unsubordinated indebtedness from time to time outstanding; 

(b)    The Notes will not be issued as Original Issue Discount Securities (as defined in the Indenture); 

(c)    The Notes will have the respective terms and will be substantially in the respective forms set forth in the specimen
Notes (attached hereto as Annex B-1 and Annex B-2); and 

(d)    The Notes will be issued in the form of one of more Global Securities and The Depository Trust Company will be the
depositary therefor. 
 [Signature page follows] 

 IN WITNESS WHEREOF, I have hereunto signed my name as of the date first above written. 

 

			
	 /s/ Charles V. Dannewitz

	Name:	 	Charles V. Dannewitz
	Title:	 	 Executive Vice President, Chief Financial

Officer

 [Signature page of Officer Certificate Pursuant to Indenture] 

 Annex A-1 

Extract from Resolutions 

of the Board of Directors of Tech Data Corporation 

Dated on January 17, 2017 

AUTHORIZATION OF 
 SHELF
REGISTRATION STATEMENT AND DEBT OFFERINGS 
 WHEREAS, Tech Data Corporation (the “Corporation”) has entered into the Interest Purchase
Agreement, dated as of September 19, 2016, between the Corporation and Avnet, Inc. providing for the acquisition of the Technology Solutions business of Avnet, Inc. (the “Acquisition”); 

WHEREAS, the Board of Directors (the “Board”) of the Corporation has determined it to be advisable and in the best interests of the
Corporation in connection with the Acquisition, to issue and sell from time to time up to an aggregate amount of $1,000,000,000 (or its equivalent at the time of issuance in any other currency) of
non-convertible debt securities, senior or subordinated, consisting of debentures, notes and/or other evidences of indebtedness representing secured or unsecured obligations of the Corporation (the “Debt
Securities”); 
 WHEREAS, the Board has determined it to be advisable and in the best interests of the Corporation to delegate to a pricing
committee the determination and approval of the terms and conditions of any such Debt Securities in light of prevailing market conditions from time to time and such other factors as such committee may deem relevant. 

Issuance of Debt Securities 

NOW, THEREFORE BE IT RESOLVED, that in addition to all other authorizations for the borrowing of money or issuance or sale of debt
securities heretofore granted and outstanding, the Corporation, be, and hereby is, authorized to issue Debt Securities in one or more transactions for aggregate proceeds of up to $1,000,000,000 (or its equivalent at the time of issuance in any other
currency) on such terms and conditions, and in one or more public, private, syndicated or other negotiated offerings or transactions, as may be determined from time to time by the Pricing Committee established in these resolutions. 

Pricing Committee 

RESOLVED, that a pricing committee (the “Pricing Committee”) is hereby established and authorized to determine the terms of
any Debt Securities issued pursuant to these resolutions (including the interest rate, maturity date, ranking and any mandatory or optional redemption or repurchase dates) and the price, or range of prices, at which any Debt Securities are

  
 A1-1 

 
to be sold and issued from time to time, together with all such other terms and conditions of such Debt Securities, which determinations by the Pricing Committee shall have the same force and
effect as determinations made by the Board. 
 RESOLVED, that Robert M. Dutkowsky, Board member and Chief Executive Officer, Charles
V. Dannewitz, Executive Vice President and Chief Financial Officer and Scott W. Walker, Corporate Vice President, Treasurer, shall serve as the Pricing Committee; that the presence of any two members of the Pricing Committee at any meeting of
the Pricing Committee shall constitute a quorum for the transaction of business; and that the vote of any two members of the Pricing Committee at which a quorum is present shall be the act of the Pricing Committee. 

Shelf Registration Statements: Other Filings and Approvals 

RESOLVED, that Robert M. Dutkowsky, Chief Executive Officer, Charles V. Dannewitz, Executive Vice President, Chief Financial
Officer, Scott W. Walker, Corporate Vice President, Treasurer, Jeffrey Taylor, Senior Vice President, Controller and David R. Vetter, Executive Vice President, Chief Legal Officer and Secretary of the Corporation (collectively, the “Authorized
Officers”) be, and each of them hereby is, authorized to prepare and file with the Securities and Exchange Commission and/or the Financial Industry Regulatory Authority one or more Registration Statements on Form
S-3 or S-4 (each, a “Registration Statement”) for Debt Securities to be offered by the Corporation, whether on a delayed or continuous basis pursuant to Rule
415 or otherwise or for one or more registered exchange offers or the secondary market resale of Debt Securities previously placed by the Corporation in any private or other negotiated transaction, in each case, pursuant to the Securities Act of
1933, as amended (the “Securities Act”), including a prospectus and any and all exhibits and other documents relating thereto and any and all amendments or supplements to each such Registration Statement, all in such forms as the officers
and directors who execute the same may deem necessary or appropriate. 
 RESOLVED, that the designation of any of the Authorized
Officers of the Corporation as agent for service of process on the Corporation, with the powers conferred upon him or her as are conferred upon such agent by the Securities Act and the rules and regulations thereunder be, and the same hereby is,
ratified and approved in all respects. 
 RESOLVED, that the Authorized Officers be, and each of them hereby is, authorized, in the
name and on behalf of the Corporation, to request acceleration of each Registration Statement (if so required under the Securities Act) so as to cause it to become effective under the Securities 

  
 A1-2 

 
Act on such date as any such Authorized Officer may determine and to execute such other instruments and do all such other things as may be necessary or advisable, in order that each such
Registration Statement shall be filed and become and remain effective under the Securities Act. 
 RESOLVED, that the Authorized
Officers be, and each of them hereby is, authorized, in the name and on behalf of the Corporation, to take any and all action that such Authorized Officer(s) may deem necessary or advisable in order to effect the registration or qualification (or
exemption therefrom) of the securities being registered under any Registration Statement under the securities or Blue Sky laws of any of the states and other jurisdictions of the United States, and any other jurisdictions outside the United States
in which such securities will be distributed or to comply with any applicable requirements and regulations of the Federal, state, local and foreign administrative or governmental agencies in each jurisdiction where the Corporation or any of its
subsidiaries conducts any business or owns any property or assets, and in connection therewith to execute, acknowledge, verify, deliver, file and publish all such applications, reports, resolutions and other papers and instruments as may be required
under such laws and to make any filings that may be required by the Financial Industry Regulatory Authority. 
 Agreements and Other
Documentation for Sale of Debt Securities 
 RESOLVED, that the Authorized Officers of the Corporation be, and each hereby
is, authorized to do or cause to be done, in the name and on behalf of the Corporation, any and all such acts and things, and to execute, deliver and file, in the name and on behalf of the Corporation, any and all such agreements (including one or
more underwriting, purchase, placement, subscription, selling agent or other distribution agreements, as applicable), applications, certificates, instructions, receipts and other documents and instruments (including if so authorized by the Pricing
Committee any registration rights agreements with respect to Debt Securities sold in any private or negotiated transaction) as any such Authorized Officer may deem necessary, advisable or appropriate in order to issue and sell any of the Debt
Securities; and that the Corporation be, and it hereby is, authorized to enter into and perform its obligations under any such agreement or other document or instrument. 

Stock Exchange Application 

RESOLVED, that the Authorized Officers are, and each of them hereby is, authorized, in the name and on behalf of the Corporation to
apply for the listing of any such Debt Securities as the Pricing Committee may deem appropriate on any U.S. or non-U.S. securities exchange, and to take all such actions and to prepare, execute and file or
cause to be filed any and all certificates, applications and other documents as any Authorized Officer may deem necessary with respect thereto. 

  
 A1-3 

 Indenture and Other Instruments 

RESOLVED, that the Corporation be, and it hereby is, authorized to enter into and perform its obligations under one or more indentures,
supplemental indentures, fiscal and paying agent agreements or other similar agreements with respect to the issuance of any Debt Securities, and any amendment thereto between the Corporation, as issuer or borrower, as the case may be, and any
trustee or agent approved by an Authorized Officer (each, an “Instrument”); that any Authorized Officer be, and each hereby is, authorized on behalf of the Corporation to execute and deliver any such Instrument and any amendments thereto,
in such form as the person executing the same on behalf of the Corporation shall approve. 
 RESOLVED, that the Corporation be, and it
hereby is, authorized to enter into and perform its obligations under any note or other evidence of the Debt Securities approved by an Authorized Officer, and that any Authorized Officer be, and each hereby is, authorized to issue, execute (manually
or by facsimile) and deliver in the name and on behalf of the Corporation such note or other evidence of the Debt Securities, in such form as the Authorized Officer executing the same on behalf of the Corporation shall approve and to affix its
corporate seal thereto. 
 RESOLVED, that the Authorized Officers are, and each of them hereby is, authorized and empowered to qualify
any applicable Instrument for Debt Securities to be offered to the public under the Trust Indenture Act of 1939, as amended. 

Appointment of Trustees and Other Agents 

RESOLVED, that the Authorized Officers be, and each of them hereby is, authorized to appoint trustees, paying agents, transfer agents,
registrars, listing agents, depositaries or clearing agents, and other agents with respect to the Debt Securities; that the Authorized Officers be, and each hereby is, authorized to make such representations and enter into such agreements necessary
or appropriate to evidence the same on behalf of the Corporation, and any amendment thereto, in such form as the Authorized Officer executing the same on behalf of the Corporation shall approve; and that, in the absence of such appointment, the
Corporation be, and hereby is, authorized to act in any of the above capacities to the extent permitted by law and to take such actions as called for by the Instruments governing the relevant Debt Securities. 

  
 A1-4 

 RESOLVED, that the Authorized Officers be, and each of them hereby is, authorized, in the
name and on behalf of the Corporation, to execute and deliver such other agreements, documents, certificates and instruments as may be required by any trustee or other agent in connection with the applicable Instrument or the Debt Securities, or
required in connection with the offer, sale or performance thereof. 
 Additional Actions 

RESOLVED, that the Authorized Officers be, and each of them with full power to act without the others hereby is, authorized and
empowered to do any and all acts and things and to sign, seal, execute, acknowledge, file, deliver and record all papers, instruments, documents and certificates and to pay all charges, fees, taxes and other expenses, from time to time necessary,
desirable or appropriate to be done, signed, sealed, executed, acknowledged, filed, delivered, recorded or paid, under any applicable law or otherwise, in the name and on behalf of the Corporation, and to certify as having been adopted by the Board
any form of resolution required by any law, regulation or agency appropriate to effectuate the purpose and intent of these resolutions or any of them and such other agreements and documents as may be executed by any Authorized Officer pursuant to
authorization granted in these resolutions or to carry out the transactions contemplated thereby; that the Authorized Officers be, and each of them with full power to act without the others hereby is, authorized and empowered to retain, in the name
and on behalf of the Corporation, such financial advisors, legal counsel and such other advisors, consultants, or experts necessary or appropriate to carry out the actions contemplated in these resolutions; to secure any appropriate advice and
opinions from such advisors, consultants or experts; to pay all fees and expenses incurred by the Corporation in connection with the issuance, offering and sale of Debt Securities, including, but not limited to, all fees and expenses appropriate to
effectuate the purpose and intent of these resolutions or any of them and the issuance of Debt Securities and such other agreements and documents as may be executed by any Authorized Officer pursuant to authorization granted in these resolutions or
to carry out the transactions contemplated thereby; that each Authorized Officer may, by a written power-of-attorney, authorize any other officer, employee or agent of,
or counsel to, the Corporation to take any and all actions and to execute and deliver any and all certificates, documents and instruments referred to in these resolutions in place of or on behalf of such Authorized Officer, with full power as if
such Authorized Officer were taking such action himself; and that any or all actions heretofore taken by any officer or officers of the Corporation with respect to any matter referred to or contemplated by any of the these resolutions be, and hereby
are, ratified and confirmed as the act and deed of the Corporation. 

  
 A1-5 

 Further Resolutions 

RESOLVED, that in connection with the transactions contemplated in the foregoing resolutions, the Authorized Officers be, and each of
them hereby is, authorized, in the name and on behalf of the Corporation, to certify any more formal or detailed resolutions as such officers may deem necessary or appropriate to effectuate the intent of the foregoing resolutions and that such
officers be, and each of them hereby is, authorized and directed to annex such resolutions to these resolutions, and thereupon such resolutions shall be deemed adopted as and for the resolutions of this Board as if set forth in these resolutions.

  
 A1-6 

 Annex A-2 

Extract from Resolutions of the 

Pricing Committee of Tech Data Corporation 

Dated on January 24, 2017 

WHEREAS, on January 17, 2017, the Board authorized, pursuant to resolutions adopted by the Board among other things, the authority to file with
the Securities and Exchange Commission (the “SEC”) a shelf registration statement and related filings in respect of debt securities (the “Debt Securities”) of the Corporation; 

WHEREAS, on January 17, 2017, the Corporation filed with the SEC a registration statement on Form S-3 (No.
333-215579) (the “Registration Statement”); 
 WHEREAS, on January 17, 2017, the Board
authorized, pursuant to resolutions adopted by the Board (the “Financing Resolutions”) among other things, the authority to issue and sell from time to time up to $1,000,000,000 of the Debt Securities pursuant to the Registration
Statement; 
 WHEREAS, the Financing Resolutions authorized the Pricing Committee to determine the interest rate, maturity date, ranking and any
mandatory or optional redemption or repurchase dates for any such Debt Securities, and the price, or range of prices, at which any such indebtedness may be sold or placed and issued from time to time, together with all such other terms and
conditions of such indebtedness and the offering or placement and sale thereof; and 
 WHEREAS, the Pricing Committee deems it advisable and in the
best interests of the Corporation to adopt the following resolutions with respect to the issuance and sale of the Debt Securities. 
 NOW
THEREFORE IT IS, 
 RESOLVED, that the Pricing Committee has determined that it is in the best interests of the Corporation and
its stockholders to authorize the issuance and sale of the Corporation’s 3.700% Senior Notes due 2022 ( the “2022 Notes”) and the Corporation’s 4.950% Senior Notes due 2027 (the “2027 Notes” and together
with the 2022 Notes, the “Notes”) pursuant to the Corporation’s Indenture, dated as of January 17, 2017 (the “Indenture”), between the Corporation and MUFG Union Bank N.A., as Trustee (the
“Trustee”), substantially in the form filed as Exhibit 4-A to the Registration Statement; and 

FURTHER RESOLVED, that the Pricing Committee hereby approves and authorizes the issuance and sale to the Underwriters (as defined below)
of an aggregate principal amount of $1,000,000,000 of the Notes at a price and with such terms as set forth in the term sheet containing the final terms of the Notes attached hereto as Exhibit A, with such changes therein, additions thereto
and deletions therefrom as may be approved by the Chief Financial Officer and set forth in an Officer’s Certificate (as defined in the Indenture) in accordance with the Indenture; and 

  
 A2-1 

 FURTHER RESOLVED, that the Underwriting Agreement, dated January 24, 2017 (the
“Underwriting Agreement”), between the Corporation and Merrill Lynch, Pierce, Fenner & Smith Incorporated, Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as representatives of the underwriters named in the
Underwriting Agreement (the “Underwriters”), providing for the purchase and sale of $1,000,000,000 aggregate principal amount of the Notes substantially in the form submitted to the Pricing Committee, be and they hereby are, in all
respects approved, with such changes therein, additions thereto and deletions therefrom as may be approved by any Authorized Officer (as defined in the Financing Resolutions); and 

FURTHER RESOLVED, that (i) payment of the principal of, and interest on, the Notes will be made at the Corporate Trust Office (as
defined in the Indenture), or any Place of Payment (as defined in the Indenture), in accordance with the Indenture and the Notes, (ii) the Notes may be presented for registration of transfer or exchange at the Corporate Trust Office of the
Trustee or any Place of Payment and (iii) notices and demands to or upon the Corporation in respect of the Notes may be sent in writing and mailed, delivered, or telefaxed to Tech Data Corporation, 5350 Tech Data Drive, Clearwater, Florida
33760, Attention: Executive Vice President, Chief Legal Officer and Secretary, Telecopy No.: (727) 538-7803; and 

FURTHER RESOLVED, that each of the Notes will be represented by one or more global notes that will be deposited with and registered in
the name of The Depository Trust Corporation or its nominee; and 
 FURTHER RESOLVED, that in connection with the transactions
contemplated in the foregoing resolutions, the Authorized Officers (as defined in the Financing Resolutions) be, and each of them hereby is, authorized, in the name and on behalf of the Corporation, to take, or to cause to be taken, any and all
actions any such Authorized Officer may deem necessary or appropriate, and to certify any more formal or detailed resolutions as such officers may deem necessary or appropriate, in each case, to effectuate the intent of the foregoing resolutions and
that such officers be, and each of them hereby is, authorized and directed to annex any such resolutions to these resolutions, and thereupon such resolutions shall be deemed adopted as and for the resolutions of this Pricing Committee as if set
forth at length in these resolutions; and 
 FURTHER RESOLVED, that any actions previously taken by any officer, employee or agent of
the Corporation in connection with the matters set forth in the foregoing resolutions and the transactions contemplated thereby be, and hereby are, in all respects approved, ratified and confirmed. 

  
 A2-2 

 Exhibit A 

Term Sheet 
 Filed
Pursuant to Rule 433 under the Securities Act of 1933 
 Registration Statement
No. 333-215579 
 Issuer Free Writing Prospectus dated January 24, 2017 

Tech Data Corporation 

Pricing Term Sheet 
 This pricing term
sheet should be read in conjunction with the preliminary prospectus supplement dated January 24, 2017 and the accompanying prospectus. The information in this pricing term sheet supersedes the information in the preliminary prospectus
supplement and the accompanying prospectus to the extent inconsistent with the information in the preliminary prospectus supplement and the accompanying prospectus. In all other respects, this pricing term sheet is qualified in its entirety by
reference to the preliminary prospectus supplement and accompanying prospectus. 
 $500,000,000 3.700% Senior Notes due 2022 

 

			
	Issuer:	  	Tech Data Corporation
		
	Title of Securities:	  	3.700% Senior Notes due 2022
		
	Public Offering Price:	  	99.848%
		
	Aggregate Principal Amount Offered:	  	$500,000,000
		
	Net Proceeds Before Expenses:	  	$496,240,000
		
	Trade Date:	  	January 24, 2017
		
	Settlement Date*:	  	January 31, 2017 (T+5)
		
	Maturity Date:	  	February 15, 2022
		
	Interest Rate:	  	3.700% per annum, subject to adjustment upon the occurrence of the events described under “Description of the Notes—Interest Rate Adjustment” in the preliminary prospectus supplement.
		
	Yield to Maturity:	  	3.733%
		
	Spread to Benchmark Treasury:	  	T+180 bps
		
	Benchmark Treasury:	  	2.000% due December 31, 2021
		
	Benchmark Treasury Price and Yield:	  	100-10; 1.933%
		
	Interest Payment Dates:	  	February 15 and August 15 of each year, beginning on August 15, 2017
		
	Make-Whole Call:	  	Prior to January 15, 2022 at T+30 bps
		
	Par Call:	  	On or after January 15, 2022
		
	Special Mandatory Redemption:	  	101% of principal plus accrued and unpaid interest, if the Proposed Acquisition (as defined in the preliminary prospectus supplement)

  
 A2-3 

			
		  	has not occurred on or prior to the earlier of (i) June 19, 2017 (provided that, if the termination date of the Acquisition Agreement (as defined in the preliminary prospectus supplement) is extended, this date will also
be extended to the same extended termination date, but in no case will this date be extended beyond September 15, 2017) and (ii) the date the Acquisition Agreement is terminated.
		
	CUSIP / ISIN:	  	878237 AG1 / US878237AG14
		
	Anticipated Ratings**:	  	Baa3 (Negative Outlook) (Moody’s) / BBB- (Negative Outlook) (S&P)
		
	Joint Book-Running Managers:	  	Merrill Lynch, Pierce, Fenner & Smith
		  	                     Incorporated
		  	Citigroup Global Markets Inc.
		  	J.P. Morgan Securities LLC
		
	Co-Managers:	  	MUFG Securities Americas Inc.
		  	PNC Capital Markets LLC
		  	Scotia Capital (USA) Inc.
		  	BNP Paribas Securities Corp.
		  	Mizuho Securities USA Inc.
		  	UniCredit Capital Markets LLC
		  	Skandinaviska Enskilda Banken AB (publ)
		  	TD Securities (USA) LLC
		  	Raymond James & Associates, Inc.
	
	 $500,000,000 4.950% Senior Notes due 2027

 

	Issuer:	  	Tech Data Corporation
		
	Title of Securities:	  	4.950% Senior Notes due 2027
		
	Public Offering Price:	  	99.833%
		
	Aggregate Principal Amount Offered:	  	$500,000,000
		
	Net Proceeds Before Expenses:	  	$495,915,000
		
	Trade Date:	  	January 24, 2017
		
	Settlement Date*:	  	January 31, 2017 (T+5)
		
	Maturity Date:	  	February 15, 2027
		
	Interest Rate:	  	4.950% per annum, subject to adjustment upon the occurrence of the events described under “Description of the Notes—Interest Rate Adjustment” in the preliminary prospectus supplement.
		
	Yield to Maturity:	  	4.971%
		
	Spread to Benchmark Treasury:	  	T+250 bps
		
	Benchmark Treasury:	  	2.000% due November 15, 2026
		
	Benchmark Treasury Price and Yield:	  	95-29+; 2.471%
		
	Interest Payment Dates:	  	February 15 and August 15 of each year, beginning on August 15, 2017

  
 A2-4 

			
	Make-Whole Call:	  	Prior to November 15, 2026 at T+40 bps
		
	Par Call:	  	On or after November 15, 2026
		
	Special Mandatory Redemption:	  	101% of principal plus accrued and unpaid interest, if the Proposed Acquisition (as defined in the preliminary prospectus supplement) has not occurred on or prior to the earlier of (i) June 19, 2017 (provided that, if the
termination date of the Acquisition Agreement (as defined in the preliminary prospectus supplement) is extended, this date will also be extended to the same extended termination date, but in no case will this date be extended beyond
September 15, 2017) and (ii) the date the Acquisition Agreement is terminated.
		
	CUSIP / ISIN:	  	878237 AH9 / US878237AH96
		
	Anticipated Ratings**:	  	Baa3 (Negative Outlook) (Moody’s) / BBB- (Negative Outlook) (S&P)
		
	Joint Book-Running Managers:	  	 Merrill Lynch, Pierce, Fenner & Smith

                     Incorporated

		  	Citigroup Global Markets Inc.
		  	J.P. Morgan Securities LLC
		
	Co-Managers:	  	MUFG Securities Americas Inc.
		  	PNC Capital Markets LLC
		  	Scotia Capital (USA) Inc.
		  	BNP Paribas Securities Corp.
		  	Mizuho Securities USA Inc.
		  	UniCredit Capital Markets LLC
		  	Skandinaviska Enskilda Banken AB (publ)
		  	TD Securities (USA) LLC
		  	Raymond James & Associates, Inc.

  

	**	Note: A securities rating is not a recommendation to buy, sell or hold a security and may be subject to revision or withdrawal at any time. 

	*	The issuer expects that delivery of the notes will be made to investors on or about January 31, 2017, which will be the fifth business day following the date of this pricing term sheet (such settlement being
referred to as “T+5”). Under Rule 15c6-1 under the Securities Exchange Act of 1934, as amended, trades in the secondary market are required to settle in three business days, unless the parties to any
such trade expressly agree otherwise. Accordingly, purchasers who wish to trade notes on the date of the prospectus supplement or the next succeeding business day will be required, by virtue of the fact that the notes initially settle in T+5, to
specify an alternate settlement arrangement at the time of any such trade to prevent a failed settlement. Purchasers of the notes who wish to trade the notes on the date of the prospectus supplement of the next succeeding business day should consult
their advisors. 

 The issuer has filed a registration statement (including a prospectus supplement and accompanying prospectus) with the
SEC for the offering to which this communication relates. Before you invest, you should read the prospectus supplement and accompanying prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete
information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send to
you the prospectus if you request it by calling Merrill Lynch, Pierce, Fenner & Smith Incorporated at (800) 294-1322 (toll free), Citigroup Global Markets Inc. at (800)
831-9146 (toll free) or J.P. Morgan Securities LLC at (212) 834-4533 (collect). 

  
 A2-5 

 ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE
DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM. 

  
 A2-6 

 Annex B-1 

GLOBAL SECURITY 
 UNLESS AND UNTIL IT IS
EXCHANGED IN WHOLE OR IN PART FOR THE INDIVIDUAL SECURITIES REPRESENTED HEREBY, THIS GLOBAL SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR
ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY. 

TECH DATA CORPORATION 
 3.700%
Senior Note due 2022 
 PRINCIPAL AMOUNT: $500,000,000 
 CUSIP:
878237 AG1 
 No.: R-001 

TECH DATA CORPORATION, a Florida corporation (the “Company”, which term includes any successor thereto under the Indenture referred
to on the reverse hereof), for value received, hereby promises to pay to Cede & Co., or registered assigns, at the office or agency of the Company maintained for such purpose, which shall initially be the Corporate Trust Office of the
Trustee, the principal sum of FIVE HUNDRED MILLION DOLLARS ($500,000,000) (or such other principal amount as shall be set forth in the Schedule of Increases or Decreases in Note attached hereto) on February 15, 2022, in the coin or currency of
the United States, and to pay interest thereon from January 31, 2017 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually in arrears on February 15 and August 15 of each
year, beginning on August 15, 2017, on said principal sum at said office or agency, in like coin or currency, at the rate of 3.700% per annum, on the basis of a 360-day year consisting of twelve 30-day months, until the principal hereof is paid or duly provided for or made available for payment and (to the extent that the payment of such interest shall be legally enforceable) at such rate on any overdue
principal and premium and on any overdue installment of interest; provided that payment of interest may be made at the option of the Company by check mailed to the address of the person entitled thereto as such address shall appear on the
Register or by wire transfer as provided in the Indenture. 
 The interest so payable, and punctually paid or duly provided for, on any
Interest Payment Date will, as provided in the Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on the Record Date for such interest, which shall be
February 1 or August 1 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date. Any such interest not so punctually paid or duly provided for will forthwith cease to be payable to the Holder on such

  
 B1-1 

 
Record Date and may either be paid to the person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for the
payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner not
inconsistent with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as, more fully provided in said Indenture. 

Reference is made to the further provisions of this Note set forth on the reverse hereof. Such further provisions shall for all purposes have
the same effect as though fully set forth at this place. 
 This Note shall not be valid or become obligatory for any purpose until the
certificate of authentication hereon shall have been manually signed by the Trustee under the Indenture referred to on the reverse hereof. 

  
 B1-2 

 IN WITNESS WHEREOF, TECH DATA CORPORATION has caused this Note to be duly executed. 

 

			
	TECH DATA CORPORATION
		
	By:	 	  

		 	Name:
		 	Title:

  
 B1-3 

 CERTIFICATE OF AUTHENTICATION 

This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. 

Date of authentication: January 31, 2017 
  

			
	 MUFG UNION BANK N.A.
 as
Trustee

		
	By:	 	  

		 	Authorized Signatory

  
 B1-4 

 REVERSE OF NOTE 

TECH DATA CORPORATION 
 3.700%
Senior Note due 2022 
 General 
 This
Note is one of a duly authorized issue of securities of the Company (hereinafter called the “Securities”) of the series hereinafter specified, all issued or to be issued under and pursuant to an Indenture, dated as of January 17, 2017
(the “Indenture”), duly executed and delivered by the Company to MUFG Union Bank, N.A., as Trustee (the “Trustee,” which term includes any successor trustee), to which the Indenture and all indentures supplemental thereto
reference is hereby made for a description of the rights, limitations of rights, obligations, duties and immunities thereunder of the Trustee, the Company and the Holders of the Securities. The Securities may be issued in one or more series, which
different series may be issued in various aggregate principal amounts, may mature at different times, may bear interest (if any) at different rates, may be subject to different redemption provisions (if any), may be subject to different sinking,
purchase or analogous funds (if any) and may otherwise vary as in the Indenture provided. This Note is one of a series designated as the 3.700% Senior Notes due 2022 of the Company (the “Notes”), limited in aggregate principal amount to
$500,000,000; provided, however, that the Company, without notice to or consent of the Holders, may issue additional Securities of this series and thereby increase such principal amount in the future, on the same terms and conditions
(except for issue date, public offering price and, if applicable, the date from which interest accrues and the first Interest Payment Date). Any additional Securities shall be issued under a separate CUSIP number unless: (i) the additional
notes and the outstanding notes of the original series are treated as part of the same “issue” of debt instruments for U.S. Federal income tax purposes, (ii) such additional notes have no more than a de minimis amount of original
issue discount for U.S. federal income tax purposes or (iii) such issuance would constitute a “qualified reopening” for U.S. federal income tax purposes. 

Interest shall be computed on the basis of a 360-day year consisting of twelve 30-day months. The Company shall pay interest on overdue principal, premium, if any, and, to the extent lawful, on overdue installments of interest at the rate per annum borne by this Note. If a payment date is not
a Business Day as defined in the Indenture at a Place of Payment, payment may be made at that place on the next succeeding day that is a Business Day, and no interest shall accrue for the intervening period. 

In case an Event of Default (as defined in the Indenture) with respect to the Notes shall have occurred and be continuing, the principal
hereof and the interest accrued hereon, if any, may be declared, and upon such declaration shall become, due and payable, in the manner, with the effect and subject to the conditions provided in the Indenture. 

The Indenture contains provisions that provide that the Company and the Trustee may enter into an indenture or indentures supplemental hereto
for the purpose of amending any provisions of the Indenture or of modifying in any manner the rights of the Holders of the Securities of such series to be affected with the written consent of the Holders of a majority in

  
 B1-5 

 
principal amount of the Outstanding Securities of such series affected by such amendment voting separately; provided that, without the consent of each Holder of the Securities of each
series affected thereby, an amendment may not: (i) extend the Stated Maturity of the principal of, or any installment of interest on, such Holder’s Security, or reduce the principal amount thereof or the interest thereon or any premium
payable upon redemption thereof, or change the Currency in which the principal of and premium, if any, or interest on such Security is denominated or payable, or reduce the amount of the principal of an Original Issue Discount Security that would be
due and payable upon a declaration of acceleration of the Maturity thereof, or impair the right to institute suit for the enforcement of any payment on or after the Stated Maturity thereof (or, in the case of redemption, on or after the Redemption
Date), or materially adversely affect the economic terms of the Holder’s right to convert or exchange any Security as may be provided in the Indenture; (ii) reduce the percentage in principal amount of the Outstanding Securities of any
series, the consent of whose Holders is required for any supplemental indenture, or the consent of whose Holders is required for any waiver of compliance with certain provisions of the Indenture or certain Defaults hereunder and their consequences
provided for in the Indenture; (iii) modify any of the provisions of the Indenture governing amendments or waivers with the consent of Holders except to increase any such percentage or to provide that certain other provisions of the Indenture
cannot be modified or waived without the consent of the Holder of each Outstanding Security affected thereby; or (iv) modify, without the written consent of the Trustee, the rights, duties or immunities of the Trustee. 

It is also provided in the Indenture that, subject to certain conditions and exceptions, the Holders of a majority in aggregate principal
amount of a series of Securities at the time Outstanding may on behalf of the Holders of all of the Securities of such series waive any past Default or Event of Default hereunder and its consequences except a Default in the payment of interest or
any premium on or the principal of the Securities of such series or a Default in respect of a covenant or provision of the Indenture that cannot be modified or amended without the consent of the Holder of each Outstanding Security of such series.
Upon any such waiver, the Company, the Trustee and the Holders of the Securities of such series shall be restored to their former positions and rights under the Indenture, respectively; provided that no such waiver shall extend to any subsequent or
other Default or Event of Default or impair any right consequent thereon. 
 No reference herein to the Indenture and no provision of this
Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and interest on this Note in the manner, at the place, at the respective times, at the rate and in the coin or
currency herein prescribed. 
 The Notes will be issued in fully registered form without coupons in minimum denominations of $2,000 and
multiples of $1,000 in excess thereof and are transferable and exchangeable at the office or agency of the Company maintained for such purpose, which shall initially be the Corporate Trust Office of the Trustee, and in the manner and subject to the
limitations provided in the Indenture. 
 Upon due presentment for registration of transfer of this Note at the office or agency of the
Company maintained for such purpose, which shall initially be the Corporate Trust 

  
 B1-6 

 
Office of the Trustee, a new Note or Notes of authorized denominations for an equal aggregate principal amount shall be issued to the transferee in exchange therefor, subject to the limitations
provided in the Indenture, without charge except for any tax or other governmental charge imposed in connection therewith. 
 The Company,
the Trustee and any agent of the Company or the Trustee may deem and treat the registered Holder hereof as the absolute owner of this Note (whether or not this Note shall be overdue and notwithstanding any notation of ownership or other writing
hereon), for the purpose of receiving payment of, or on account of, the principal hereof and, subject to the provisions hereof, interest hereon, and for all other purposes, and neither the Company nor the Trustee nor any agent of the Company or the
Trustee shall be affected by any notice to the contrary. 
 No recourse under or upon any obligation, covenant or agreement contained in the
Indenture or any indenture supplemental thereto or in any Note, or because of any indebtedness evidenced thereby, shall be had against any incorporator as such, or against any past, present or future stockholder, officer or director, as such, of the
Company or of any successor, either directly or through the Company or any successor, under any rule of law, statute or constitutional provision or by the enforcement of any assessment or by any penalty or otherwise, all such liability being
expressly waived and released by the acceptance hereof and as part of the consideration for the issue hereof. 
 Terms used herein that are
defined in the Indenture shall have the respective meanings assigned thereto in the Indenture. 
 The laws of the State of New York (without
regard to conflicts of laws principles thereof) shall govern this Note. 
 Optional Redemption 

At any time prior to the Par Call Date (as defined below), the Company shall have the right at its option to redeem the Notes, in whole or from
time to time in part, at a Redemption Price equal to the greater of: 
  

	 	(i)	100% of the principal amount of the Notes to be redeemed; or 

  

	 	(ii)	the sum of the present values of the remaining scheduled payments of principal and interest on the Notes to be redeemed (exclusive of interest accrued to the Redemption Date) from the Redemption Date to the Par Call
Date, discounted to the Redemption Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at a rate equal to the sum of the applicable
Treasury Rate plus 30 basis points, together with, accrued and unpaid interest on the principal amount of the Notes to be redeemed to, but not including, the Redemption Date. 

At any time on or after the Par Call Date, the Company shall have the right at its option to redeem the Notes, at any time in whole or from
time to time in part, at a 

  
 B1-7 

 
Redemption Price equal to 100% of the principal amount of the Notes to be redeemed, plus, accrued and unpaid interest, if any, on the principal amount of the Notes to be redeemed to, but
excluding, the Redemption Date. 
 For the purposes of determining the Redemption Price, “Treasury Rate” means, with respect to
any Redemption Date, the rate per year equal to: (1) the yield, under the heading which represents the average for the immediately preceding week, appearing in the most recently published statistical release designated “H.15(519)” or
any successor publication which is published weekly by the Board of Governors of the Federal Reserve System and which establishes yields on actively traded United States Treasury securities adjusted to constant maturity under the caption
“Treasury Constant Maturities,” for the maturity corresponding to the applicable Comparable Treasury Issue; provided that, if no maturity is within three months before or after the Remaining Life of the Notes to be redeemed, yields for the
two published maturities most closely corresponding to the applicable Comparable Treasury Issue shall be determined and the Treasury Rate shall be interpolated or extrapolated from those yields on a straight line basis, rounding to the nearest
month; or (2) if such release (or any successor release) is not published during the week preceding the calculation date or does not contain such yields, the rate per year equal to the semiannual equivalent yield to maturity of the applicable
Comparable Treasury Issue, calculated using a price for the applicable Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the related Comparable Treasury Price for such redemption date. The Treasury Rate shall be
calculated on the third business day preceding the redemption date. 
 “Comparable Treasury Issue” means the United States
Treasury security selected by an Independent Investment Banker as having a maturity comparable to the remaining term (“Remaining Life”) of the Notes to be redeemed that would be utilized, at the time of selection and in accordance with
customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of such Notes (assuming, for this purpose, such Notes mature on the Par Call Date). “Independent Investment
Banker” means one of the Reference Treasury Dealers that the Company appoints to act as the Independent Investment Banker from time to time. 

“Comparable Treasury Price” means, with respect to any redemption date, (1) the average of the Reference Treasury Dealer
Quotations for such redemption date, after excluding the highest and lowest Reference Treasury Dealer Quotations, or (2) if the Independent Investment Banker obtains fewer than four such Reference Treasury Dealer Quotations, the average of all
such quotations. 
 “Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and any
redemption date, the average, as determined by the Independent Investment Banker, of the bid and asked prices for the applicable Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the
Independent Investment Banker by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the third business day preceding such redemption date. As used in the immediately preceding sentence and in the definition of “Treasury
Rate” above, the term “business day” means any day that is not a Saturday, Sunday or other day on which commercial banks in New York City 

  
 B1-8 

 
are authorized or obligated by law or executive order to close. “Reference Treasury Dealer” means (1) each of Citibank Global Markets Inc., J.P. Morgan Securities LLC and
Merrill Lynch, Pierce, Fenner & Smith Incorporated and their respective successors, unless any of them ceases to be a primary U.S. Government securities dealer in New York City (a “Primary Treasury Dealer”), in which case the
Company shall substitute another Primary Treasury Dealer and (2) any other Primary Treasury Dealer selected by the Company. 

“Par Call Date” means January 15, 2022. 

Special Mandatory Redemption 
 In the
event the closing of the Proposed Acquisition has not occurred on or prior to the earlier of (i) June 19, 2017 (provided that, if the termination date of the Acquisition Agreement is extended, this date will also be extended to the same
extended termination date, but in no case will this date be extended beyond September 15, 2017) and (ii) the date the Acquisition Agreement is terminated (each, a “Special Mandatory Redemption Event”), the Company shall redeem
the Notes in whole at a special mandatory redemption price (the “Special Mandatory Redemption Price”) equal to 101% of the aggregate principal amount of the Notes, plus accrued and unpaid interest on the principal amount of the Notes to,
but not including, the Special Mandatory Redemption Date (as defined below). Upon the occurrence of a Special Mandatory Redemption Event, the Company shall promptly (but in no event later than 10 Business Days following such Special Mandatory
Redemption Event) cause notice to be delivered electronically or mailed, with a copy to the Trustee, to each holder at its registered address (such date of notification to the holders, the “Redemption Notice Date”). The notice will inform
holders that the Notes will be redeemed on the 30th day (or if such day is not a Business Day, the first Business Day thereafter) following the Redemption Notice Date (such date, the “Special Mandatory Redemption Date”) and that all of the
outstanding Notes will be redeemed at the Special Mandatory Redemption Price on the Special Mandatory Redemption Date automatically and without any further action by the holders of the Notes. At or prior to 12:00 p.m., New York City time, on the
Business Day immediately preceding the Special Mandatory Redemption Date, the Company shall deposit with the Trustee funds sufficient to pay the Special Mandatory Redemption Price for the Notes. If such deposit is made as provided above, the Notes
will cease to bear interest on and after the Special Mandatory Redemption Date. There is no escrow account for, or security interest in, the proceeds of the offering for the benefit of the holders of the Notes. 

For purposes of the immediately preceding paragraph, the following terms have the following definitions: 

“Acquisition Agreement” means the interest purchase agreement signed September 19, 2016 between the Company and Avnet Inc. to
acquire all the shares of AVT Technology Solutions LLC and TS Divestco B.V., which will hold all assets and liabilities primarily relating to the technology solutions business of Avnet Inc. 

“Proposed Acquisition” means the proposed acquisition by the Company of all the shares of AVT Technology Solutions LLC and TS
Divestco B.V., which will hold all assets and liabilities primarily relating to the technology solutions business of Avnet Inc., pursuant to the Acquisition Agreement. 

  
 B1-9 

 Interest Rate Adjustment 

The annual interest rate payable on the Notes shall be subject to adjustment from time to time if either Moody’s or S&P (each as
defined in “—Change of Control Offer” below) or, if applicable, any “nationally recognized statistical rating organization” within the meaning of Section 3(a)(62) of the Exchange Act selected by the Company (as certified by
a resolution of the Company’s board of directors) as a replacement for Moody’s or S&P, as the case may be, (each, a “Substitute Rating Agency”), downgrades (or downgrades and subsequently upgrades) the credit rating assigned
to the Notes, in the manner described below. Each of Moody’s, S&P and any Substitute Rating Agency is an “Interest Rate Rating Agency,” and together they are “Interest Rate Rating Agencies.” 

If the rating assigned by Moody’s (or, if applicable, any Substitute Rating Agency) of the Notes is decreased to a rating set forth in
the immediately following table, the interest rate on the Notes shall increase such that it shall equal the interest rate payable on the Notes on the date of their initial issuance plus the percentage set forth opposite the rating in the table below
(plus, if applicable, the percentage set forth opposite the rating in the table under “—S&P Rating”): 
  

			
	 Moody’s* Rating:
	  	Interest Rate Increase:
	 Ba1
	  	0.25%
	 Ba2
	  	0.50%
	 Ba3
	  	0.75%
	 B1 or below
	  	1.00%

  

	*	Including the equivalent ratings of any Substitute Rating Agency. 

 If the rating assigned by
Moody’s (or, if applicable, any Substitute Rating Agency) of the Notes is decreased to a rating set forth in the immediately following table, the interest rate on the Notes shall increase such that it shall equal the interest rate payable on
the Notes on the date of their initial issuance plus the percentage set forth opposite the rating in the table below (plus, if applicable, the percentage set forth opposite the rating in the table under “—Moody’s Rating”): 

 

			
	 S&P Rating*:
	  	Interest Rate Increase:
	 BB+
	  	0.25%
	 BB
	  	0.50%
	 BB-
	  	0.75%
	 B+ or below
	  	1.00%

  

	*	Including the equivalent ratings of any Substitute Rating Agency. 

 If at any time the interest
rate on the Notes has been increased and any of the Interest Rate Rating Agencies subsequently upgrades its rating of the Notes, the interest rate on the Notes shall be decreased such that the interest rate for the Notes equals the interest rate
payable on the Notes on the date of their initial issuance plus the percentages set forth opposite 

  
 B1-10 

 
the ratings from the tables above in effect immediately following the upgrade in rating. If Moody’s (or any Substitute Rating Agency) subsequently upgrades its rating of the Notes to Baa3
(or its equivalent, in the case of a Substitute Rating Agency) or higher, and S&P (or any Substitute Rating Agency) upgrades its rating to BBB- (or its equivalent, in the case of a Substitute Rating
Agency) or higher, the interest rate on the Notes shall be decreased to the interest rate payable on the Notes on the date of their initial issuance (and if one such upgrade occurs and the other does not, the interest rate on the Notes shall be
decreased so that it does not reflect any increase attributable to the upgrading Interest Rate Rating Agency). In addition, the interest rates on the Notes shall permanently cease to be subject to any adjustment described above (notwithstanding any
subsequent downgrade in the ratings by any of the Interest Rate Rating Agencies) if the Notes become rated Baa1 and BBB+ (or, in either case, the equivalent thereof, in the case of a Substitute Rating Agency) or higher by Moody’s and S&P
(or, in either case, any Substitute Rating Agency), respectively (or one of these ratings if the Notes are only rated by one rating agency). 

Each adjustment required by any downgrade or upgrade in a rating set forth above, whether occasioned by the action of Moody’s or S&P
(or, in either case, any Substitute Rating Agency), shall be made independent of any and all other adjustments. In no event shall (1) the interest rate on the Notes be reduced to below the interest rate payable on the Notes on the date of their
initial issuance or (2) the total increase in the interest rate on the Notes exceed 2.00% above the interest rate payable on the Notes on the date of their initial issuance. 

No adjustments in the interest rate of the Notes shall be made solely as a result of an Interest Rate Rating Agency ceasing to provide a
rating on the Notes. If at any time less than two Interest Rate Rating Agencies provide a rating of the Notes for reasons beyond the Company’s control, the Company shall use its commercially reasonable efforts to obtain a rating of the Notes
from a Substitute Rating Agency, if one exists, in which case, for purposes of determining any increase or decrease in the interest rate on the Notes pursuant to the tables above (a) such Substitute Rating Agency shall be substituted for the
last Interest Rate Rating Agency to provide a rating of the Notes but which has since ceased to provide such rating, (b) the relative rating scale used by such Substitute Rating Agency to assign ratings to senior unsecured debt shall be
determined in good faith by an independent investment banking institution of national standing appointed by the Company and, for purposes of determining the applicable ratings included in the applicable table above with respect to such Substitute
Rating Agency, such ratings shall be deemed to be the equivalent ratings used by Moody’s or S&P, as applicable, in such table and (c) the interest rate on the Notes shall increase or decrease, as the case may be, such that the interest
rate equals the interest rate payable on the Notes on the date of their initial issuance plus the appropriate percentage, if any, set forth opposite the deemed equivalent rating from such Substitute Rating Agency in the applicable table above
(taking into account the provisions of clause (b) above) (plus any applicable percentage resulting from a decreased rating by the other Interest Rate Rating Agency). 

For so long as only one Interest Rate Rating Agency provides a rating of the Notes, any subsequent increase or decrease in the interest rate
of the Notes necessitated by a reduction or increase in the rating by the Interest Rate Rating Agency providing the rating shall be twice the applicable percentage set forth in the applicable table above. For so long as no

  
 B1-11 

 
Interest Rate Rating Agency provides a rating of the Notes, the interest rate on the Notes shall increase to, or remain at, as the case may be, 2.00% above the interest rate payable on the Notes
on the date of their initial issuance. 
 Any interest rate increase or decrease described above shall take effect from the first day of the
interest period commencing after the date on which a rating change occurs that requires an adjustment in the interest rate. If any Interest Rate Rating Agency changes its rating of the Notes more than once prior to any particular Interest Payment
Date, the last change by such agency prior to such Interest Payment Date shall control for purposes of any interest rate increase or decrease with respect to the Notes described above relating to such rating agency’s action. If the interest
rate payable on the Notes is increased as described above, the term “interest,” as used with respect to the Notes, shall be deemed to include any such additional interest unless the context otherwise requires. 

Change of Control Offer 
 If a Change of
Control Triggering Event (as defined below) occurs, unless the Company has exercised its right to redeem the Notes as provided under the Optional Redemption described above, the Company shall be required to make an offer to each Holder of Notes to
purchase all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of that Holder’s Notes at a purchase price in cash equal to 101% of the aggregate principal amount thereof, plus accrued and unpaid interest, if any,
to, but not including, the date of purchase (subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment date); provided that after giving effect to the purchase, any Notes that
remain outstanding shall have a denomination of $2,000 and integral multiples of $1,000 above that amount. 
 Within 30 days following the
date upon which the Change of Control Triggering Event has occurred or, at the Company’s option, prior to any Change of Control (as defined below) but after the public announcement of the transaction that constitutes or may constitute the
Change of Control, except to the extent that the Company has exercised its right to redeem the Notes as provided under the Optional Redemption described above, the Company shall mail a notice (a “Change of Control Offer”) to each Holder
with a copy to the Trustee describing the transaction or transactions that constitute or may constitute a Change of Control Triggering Event and offering to purchase Notes on the date specified in the notice, which date shall be no earlier than 30
days nor later than 60 days from the date such notice is delivered (other than as may be required by law) (such date, the “Change of Control Payment Date”). The notice shall, if delivered prior to the date of consummation of the Change of
Control, state that the Change of Control Offer is conditioned on the Change of Control being consummated on or prior to the Change of Control Payment Date. 

On the Change of Control Payment Date, the Company shall, to the extent lawful (a) accept for payment all Notes or portions of the Notes
properly tendered pursuant to the Change of Control Offer; (b) deposit with the Paying Agent an amount equal to the change of control payment in respect of all Notes or portions of Notes properly tendered pursuant to the Change of Control
Offer; and (c) deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers’ Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. 

  
 B1-12 

 The Company shall comply, to the extent applicable, with the requirements of Rule 14(e)-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and any other securities laws or regulations in connection with the purchase of Notes pursuant to a Change of Control
Triggering Event. To the extent that the provisions of any securities laws or regulations conflict with the terms described in the Notes, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to have
breached its obligations by virtue thereof. 
 Holders of Notes electing to have Notes purchased pursuant to a Change of Control Offer shall
be required to surrender their Notes, with the form entitled “Option of Holder to Elect Purchase” attached hereto completed, to the Paying Agent at the address specified in the notice, or transfer their Notes to the Paying Agent by
book-entry transfer pursuant to the applicable procedures of the Paying Agent, prior to the close of business on the third business day prior to the Change of Control Payment Date. 

The Company shall not be required to make a Change of Control Offer if a third party makes such an offer in the manner, at the times and
otherwise in compliance with the requirements for an offer made by the Company and such third party purchases all Notes properly tendered and not withdrawn under its offer. 

If Holders of not less than 95% in aggregate principal amount of the outstanding Notes validly tender and do not withdraw such Notes in a
Change of Control Offer and the Company, or any third party making a Change of Control Offer in lieu of the Company, as described above, purchases all of the Notes validly tendered and not withdrawn by such Holders, the Company shall have the right,
upon not less than 30 nor more than 60 days’ prior notice, given not more than 30 days following such purchase pursuant to the Change of Control Offer described above, to redeem all Notes that remain outstanding following such purchase at a
redemption price in cash equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to the Redemption Date (subject to the right of Holders of record on a record date to receive interest on the relevant Interest Payment
Date). 
 For purposes of the Change of Control Offer provisions, the following definitions are applicable: 

“Change of Control” means the occurrence of any one of the following: (a) the direct or indirect sale, lease, transfer,
conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the Company’s assets and the assets of its subsidiaries taken as a whole to any
“person” (as that term is used in Section 13(d)(3) of the Exchange Act) other than to the Company or one of its Subsidiaries; (b) the consummation of any transaction (including without limitation, any merger or consolidation) the
result of which is that any “person” (as that term is used in Section 13(d)(3) of the Exchange Act) becomes the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the Company’s outstanding Voting Stock, measured by voting power rather than number of shares; (c) the Company

  
 B1-13 

 
consolidates with, or merges with or into, any person, or any person consolidates with, or merges with or into, the Company, in any such event pursuant to a transaction in which any of the
Company’s outstanding Voting Stock or the outstanding Voting Stock of such other person is converted into or exchanged for cash, securities or other property, other than any such transaction where the shares of the Company’s Voting Stock
outstanding immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Stock of the surviving person immediately after giving effect to such transaction; (d) the first day on which the
majority of the members of the Company’s board of directors cease to be Continuing Directors; or (e) the adoption of a plan relating to the Company’s liquidation or dissolution. 

“Change of Control Triggering Event” means the occurrence of both a Change of Control and a Ratings Event. 

“Continuing Director” means, as of any date of determination, any member of the Company’s board of directors who (a) was a
member of such board of directors on January 24, 2017 or (b) was nominated for election, elected or appointed to the Company’s board of directors with the approval of a majority of the continuing directors who were members of the
Company’s board of directors at the time of such nomination, election or appointment (either by a specific vote or by approval of the Company’s proxy statement in which such member was named as a nominee for election as a director, without
objection to such nomination). 
 “Investment Grade” means a rating of Baa3 or better by Moody’s (or its equivalent under any
successor rating category of Moody’s); a rating of BBB- or better by S&P (or its equivalent under any successor rating category of S&P); and the equivalent investment grade rating from any
replacement Rating Agency or Agencies appointed by the Company. 
 “Moody’s” means Moody’s Investors Service, Inc., a
subsidiary of Moody’s Corporation, and its successors. 
 “Rating Agency” means each of Moody’s and S&P; provided
that, if either of Moody’s or S&P ceases to rate the Notes or fails to make a rating of the Notes publicly available, the Company shall appoint a replacement for such Rating Agency that is a “nationally recognized statistical rating
organization” within the meaning of Section 3(a)(62) under the Exchange Act. 
 “Ratings Event” means ratings of the Notes
are lowered by each of the Rating Agencies and the Notes rated below Investment Grade by each of the Rating Agencies in any case on any day during the period (the “Trigger Period”) commencing on the date 60 days prior to the first public
announcement by the Company of any Change of Control (or pending Change of Control) and ending 60 days following consummation of such Change of Control (which Trigger Period shall be extended for so long as the rating of the Notes is under publicly
announced consideration for a possible downgrade by either of the Rating Agencies). 
 “S&P” means Global Ratings, a division
of S&P Global, Inc., and its successors. 

  
 B1-14 

 “Voting Stock” of any specified person as of any date means the Capital Stock of such
person that is at the time entitled to vote generally in the election of the board of directors of such person. 
 Restrictive Covenants 

Restrictions on Liens. 

The Company shall not, and shall not permit any Restricted Subsidiary to, create or incur any Lien on any shares of stock of a Restricted
Subsidiary or Principal Property of the Company or of a Restricted Subsidiary, whether those shares of stock of a Restricted Subsidiary or Principal Property are owned at the date hereof or acquired afterwards, unless the Company secures or causes
the applicable Restricted Subsidiary to secure the debt securities outstanding under the Indenture (together with any other indebtedness or other obligations the terms of which (or the terms of any agreement evidencing or relating to which) require
that such indebtedness be so secured) equally and ratably with (or, at the Company’s option, prior to) all indebtedness secured by the particular Lien, so long as the indebtedness is so secured. 

This covenant does not apply in the case of: (a) the creation of any Lien on any shares of stock of a Subsidiary or any Principal
Property acquired after the date hereof (including acquisitions by way of merger or consolidation) by the Company or a Restricted Subsidiary, contemporaneously with that acquisition, or within 180 days thereafter, to secure or provide for the
payment or financing of any part of the purchase price, or the assumption of any Lien upon any shares of stock of a Subsidiary or any Principal Property acquired after the date hereof existing at the time of the acquisition, or the acquisition of
any shares of stock of a Subsidiary or any Principal Property subject to any Lien without the assumption of that Lien, provided that every Lien referred to in this clause (a) will attach only to the shares of stock of a Subsidiary or any
Principal Property so acquired and fixed improvements on that Principal Property; (b) any Lien on any shares of stock of a Subsidiary or any Principal Property existing on the date hereof; (c) any Lien on any shares of stock of a
Subsidiary or any Principal Property in favor of the Company or any Restricted Subsidiary; (d) any Lien on any Principal Property being constructed or improved securing loans to finance the construction or improvements of that property;
(e) any Lien created by a lease of any Principal Property, which under GAAP as in effect as of the date hereof would be characterized as an operating lease, whether entered into before or after the date hereof, including Liens arising under or
in connection with (i) the Synthetic Lease Facility or any refinancing, renewal or restructuring of the Synthetic Lease Facility; and (ii) any remarketing or purchase by the Company of, or any other action taken by the Company with respect
to, any Principal Property subject to the Synthetic Lease or any refinancing, renewal or restructuring thereof to the extent permitted thereby; (f) any Lien on shares of stock of a Subsidiary or any Principal Property incurred in connection
with the issuance of tax-exempt governmental obligations, including, without limitation, industrial revenue bonds and similar financings; (g) any mechanics’, materialmen’s, carriers’ or
other similar Liens arising in the ordinary course of business with respect to obligations that are not yet due or that are being contested in good faith; (h) any Lien on any shares of stock of a Subsidiary or any Principal Property for taxes,
assessments or governmental charges or levies not yet delinquent, or already delinquent but the validity of which is being contested in good faith; (i) any Lien on any Principal Property arising

  
 B1-15 

 
in connection with legal proceedings being contested in good faith, including any judgment Lien so long as execution on the Lien is stayed; (j) any landlord’s Lien on fixtures located
on premises leased by the Company or a Restricted Subsidiary in the ordinary course of business, and tenants’ rights under leases, easements and similar Liens not materially impairing the use or value of the property involved; and (k) any
renewal or extension of or substitution for any Lien permitted by any of the preceding clauses, provided that, in the case of a Lien permitted under clauses (a), (b) or (d), the indebtedness secured is not increased nor the Lien extended to any
additional assets. 
 Notwithstanding the restrictions set forth above, the Company or any Restricted Subsidiary may create or assume Liens
in addition to those permitted by the preceding paragraph, and renew, extend or replace those Liens, provided that at the time of and after giving effect to the creation, assumption, renewal, extension or replacement, Exempted Debt does not exceed
15% of Consolidated Net Tangible Assets of the Company. 
 Restrictions on Sale and Leaseback Transactions involving Principal
Properties. 
 The Company shall not, and shall not permit any Restricted Subsidiary to, sell or transfer, directly or indirectly, except
to the Company or to a Restricted Subsidiary, any Principal Property as an entirety, or any substantial portion of the Company’s Principal Property, with the intention of taking back a lease of such Principal Property, except a lease for a
period of three years or less at the end of which it is intended that the use of that Principal Property by the lessee will be discontinued. Notwithstanding the foregoing, the Company or any Restricted Subsidiary may sell any Principal Property and
lease it back for a longer period: (a) if such Principal Property is subject to the Synthetic Lease Facility or any refinancing, renewal or restructuring thereof; (b) if the Company or such applicable Restricted Subsidiary would be
entitled pursuant to the Restrictions on Liens described above to create a Lien on the Principal Property to be leased securing Funded Debt in an amount equal to the Attributable Debt with respect to the sale and
lease-back transaction without equally and ratably securing the outstanding Notes; or (c) if the Company promptly informs the Trustee of the transaction, and the Company causes an amount equal to the fair
value (as determined by resolution of its Board of Directors) of the Principal Property to be applied (1) to the purchase of other property that will constitute Principal Property having a fair value at least equal to the fair value of the
Principal Property sold, or (2) to the retirement within 120 days after receipt of the proceeds of Funded Debt incurred or assumed by the Company or a Restricted Subsidiary, including the Notes; provided further that, in lieu of applying all of
or any part of such net proceeds to such retirement, the Company may, within 75 days after the sale, deliver or cause to be delivered to the applicable trustee for cancellation debt securities evidencing Funded Debt of the Company (which may include
the Notes) or of a Restricted Subsidiary previously authenticated and delivered by the applicable trustee, and not yet tendered for sinking fund purposes or called for a sinking fund or otherwise applied as a credit against an obligation to redeem
or retire such debt securities, and an Officer’s Certificate (which will be delivered to the applicable trustee) stating that the Company elects to deliver or cause to be delivered the debt securities in lieu of retiring Funded Debt as provided
in this provision. 

  
 B1-16 

 If the Company delivers debt securities to the applicable trustee and the Company duly delivers
the Officer’s Certificate pursuant the preceding paragraph, the amount of cash that the Company shall be required to apply to the retirement of Funded Debt under this provision shall be reduced by an amount equal to the aggregate of the then
applicable optional redemption prices (not including any optional sinking fund redemption prices) of the applicable debt securities so delivered or, if there are no such redemption prices, the principal amount of those debt securities. If the
applicable debt securities provide for an amount less than the principal amount to be due and payable upon a declaration of the maturity, then the amount of cash shall be reduced by the amount of principal of those debt securities that would be due
and payable as of the date of the application upon a declaration of acceleration of the maturity pursuant to the terms of the Indenture pursuant to which those debt securities were issued. 

Notwithstanding the foregoing, the Company or any Restricted Subsidiary may enter into sale and lease-back transactions involving any
Principal Property in addition to those permitted under the Restrictions on Liens described above, without any obligation to retire any outstanding Notes or other Funded Debt; provided that at the time of entering into and giving effect to such sale
and lease-back transactions, Exempted Debt does not exceed 15% of Consolidated Net Tangible Assets of the Company. 
 For the purposes of
the foregoing restrictive covenants, the following definitions are applicable: 
 “Attributable Debt” means, as to any particular
lease, the greater of (a) the fair market value of the property subject to the lease or (b) the total net amount of rent required to be paid during the remaining term of the lease, discounted by the weighted average effective interest cost
per annum of the outstanding debt securities of all series, compounded semi-annually. 
 “Consolidated Net Tangible Assets” means
total assets after deducting all current liabilities and intangible assets as set forth in the Company’s most recent consolidated balance sheet and computed in accordance with GAAP. 

“Exempted Debt” means the sum, without duplication, of the following items outstanding as of the date Exempted Debt is being
determined (a) indebtedness of the Company and its Restricted Subsidiaries incurred after the date hereof and secured by Liens created or assumed or permitted to exist pursuant to the Restrictions on Liens described above; and(b) Attributable
Debt of the Company and its Restricted Subsidiaries in respect of all sale and lease-back transactions with regard to any Principal Property entered into pursuant to the last paragraph of the Restrictions on Sale and Leaseback Transactions Involving
Principal Properties described above. 
 “Funded Debt” means all indebtedness for money borrowed, including purchase money
indebtedness, having a maturity of more than one year from the date of its creation or having a maturity of less than one year but by its terms being renewable or extendible at the option of the obligor, beyond one year from the date of its
creation. 

  
 B1-17 

 “GAAP” means generally accepted accounting principles in the United States at the date
of any computation. 
 “Holder” or “Securityholder” mean the registered holder of any debt security with respect to
registered securities and the bearer of any unregistered security or any coupon appertaining to it, as the case may be. 
 “Lien”
means, with respect to any asset, any mortgage, lien, pledge, charge, security interest or encumbrance of any kind, or any other type of preferential arrangement that has the practical effect of creating a security interest in respect of such asset.
For the purposes of this Indenture, the Company or any Subsidiary shall be deemed to own, subject to a Lien, any asset that the Company has acquired or holds subject to the interest of a vendor or lessor under any conditional sale agreement, capital
lease or other title retention agreement relating to such asset. 
 “Principal Property” means the Company’s corporate
headquarters and any warehouse or distribution center, together with any land, land improvements, buildings and fixtures related thereto, owned or leased at the date hereof or acquired after that date by the Company or any of its Restricted
Subsidiaries and which is located within the United States, other than: (a) any property which in the opinion of the Company’s Board of Directors is not of material importance to the total business conducted by the Company as an entirety
or (b) any portion of a particular property which is similarly found not to be of material importance to the use or operation of such property. 

“Restricted Subsidiary” means a Subsidiary of the Company (a) of which substantially all the property is located, or
substantially all the business is carried on, within the United States; and (b) which owns a Principal Property. 
 “Synthetic
Lease Facility” means the Fourth Amended and Restated Lease Agreement, dated as of June 27, 2013, between the Company, as lessee, and SunTrust Bank, as lessor, and each Operative Agreement (as defined therein). 

  
 B1-18 

 ASSIGNMENT 

FOR VALUE RECEIVED, the undersigned hereby sell(s), assign(s) and transfer(s) unto 

[PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE] 
  

 
  

 
 [PLEASE PRINT OR TYPE NAME AND
ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE] 
  
  

the within Note and all rights thereunder, hereby irrevocably constituting and appointing
                                         
                                Attorney to transfer such Note on the books of the Issuer,
with full power of substitution in the premises. 
      Signature: 

 

			
	
Dated:                  
  
	  	  

		  	NOTICE: The signature to this assignment must correspond with the name as written upon the face of the within Note in every particular without alteration or enlargement or any change whatsoever.

  
 B1-19 

 SIGNATURE GUARANTEE 

[Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar, which requirements
include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for, STAMP, all
in accordance with the Securities Exchange Act of 1934, as amended.] 

  
 B1-20 

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Note purchased by the Company pursuant to a Change of Control Offer, check the box below: 

 
 ☐ 

If you want to elect to have only part of the Note purchased by the Company pursuant to a Change of Control Offer, state the amount you elect
to have purchased: $________ 
 Date:____________________ 

Your Signature:
                       ____________________________________ 

                       
                          (Sign exactly as your name appears on the face of this Note) 

Tax Identification No.:             ____________________________________ 

Signature
Guarantee:                ____________________________________ 

Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar, which requirements
include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for, STAMP, all
in accordance with the Securities Exchange Act of 1934, as amended. 

  
 B1-21 

 SCHEDULE OF INCREASES OR DECREASES IN NOTE 

The initial principal amount of this Note is $500,000,000. The following increases or decreases in a part of this Note have been made: 

 

									
	 Date
	  	 Amount of

decrease in

principal

amount of this

Note
	  	 Amount of

increase in

principal

amount of this

Note
	  	 Principal

amount of this
Note following
such decrease

(or increase)
	  	 Signature of

authorized

signatory of

Trustee

		  		  		  		  	

  
 B1-22 

 Annex B-2 

GLOBAL SECURITY 
 UNLESS AND UNTIL IT IS
EXCHANGED IN WHOLE OR IN PART FOR THE INDIVIDUAL SECURITIES REPRESENTED HEREBY, THIS GLOBAL SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR
ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY. 

TECH DATA CORPORATION 
 4.950%
Senior Note due 2027 
 PRINCIPAL AMOUNT: $500,000,000 
 CUSIP:
878237 AH9 
 No.: R-001 

TECH DATA CORPORATION, a Florida corporation (the “Company”, which term includes any successor thereto under the Indenture referred
to on the reverse hereof), for value received, hereby promises to pay to Cede & Co., or registered assigns, at the office or agency of the Company maintained for such purpose, which shall initially be the Corporate Trust Office of the
Trustee, the principal sum of FIVE HUNDRED MILLION DOLLARS ($500,000,000) (or such other principal amount as shall be set forth in the Schedule of Increases or Decreases in Note attached hereto) on February 15, 2027, in the coin or currency of
the United States, and to pay interest thereon from January 31, 2017 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually in arrears on February 15 and August 15 of each
year, beginning on August 15, 2017, on said principal sum at said office or agency, in like coin or currency, at the rate of 4.950% per annum, on the basis of a 360-day year consisting of twelve 30-day months, until the principal hereof is paid or duly provided for or made available for payment and (to the extent that the payment of such interest shall be legally enforceable) at such rate on any overdue
principal and premium and on any overdue installment of interest; provided that payment of interest may be made at the option of the Company by check mailed to the address of the person entitled thereto as such address shall appear on the
Register or by wire transfer as provided in the Indenture. 
 The interest so payable, and punctually paid or duly provided for, on any
Interest Payment Date will, as provided in the Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on the Record Date for such interest, which shall be
February 1 or August 1 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date. Any such interest not so 

  
 B2-1 

 
punctually paid or duly provided for will forthwith cease to be payable to the Holder on such Record Date and may either be paid to the person in whose name this Security (or one or more
Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10
days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be required
by such exchange, all as, more fully provided in said Indenture. 
 Reference is made to the further provisions of this Note set forth on
the reverse hereof. Such further provisions shall for all purposes have the same effect as though fully set forth at this place. 
 This
Note shall not be valid or become obligatory for any purpose until the certificate of authentication hereon shall have been manually signed by the Trustee under the Indenture referred to on the reverse hereof. 

  
 B2-2 

 IN WITNESS WHEREOF, TECH DATA CORPORATION has caused this Note to be duly executed. 

 

					
	TECH DATA CORPORATION
		
	By:	 	  

		 	Name: Charles V. Dannewitz
		 	Title: Executive Vice President, Chief Financial Officer

  
 B2-3 

 CERTIFICATE OF AUTHENTICATION 

This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. 

Date of authentication: January 31, 2017 
  

			
	 MUFG UNION BANK N.A.
 as
Trustee

		
	By:	 	  

		 	Authorized Signatory

  
 B2-4 

 REVERSE OF NOTE 

TECH DATA CORPORATION 
 4.950%
Senior Note due 2027 
 General 
 This
Note is one of a duly authorized issue of securities of the Company (hereinafter called the “Securities”) of the series hereinafter specified, all issued or to be issued under and pursuant to an Indenture, dated as of January 17, 2017
(the “Indenture”), duly executed and delivered by the Company to MUFG Union Bank, N.A., as Trustee (the “Trustee,” which term includes any successor trustee), to which the Indenture and all indentures supplemental thereto
reference is hereby made for a description of the rights, limitations of rights, obligations, duties and immunities thereunder of the Trustee, the Company and the Holders of the Securities. The Securities may be issued in one or more series, which
different series may be issued in various aggregate principal amounts, may mature at different times, may bear interest (if any) at different rates, may be subject to different redemption provisions (if any), may be subject to different sinking,
purchase or analogous funds (if any) and may otherwise vary as in the Indenture provided. This Note is one of a series designated as the 4.950 % Senior Notes due 2027 of the Company (the “Notes”), limited in aggregate principal amount
to $500,000,000; provided, however, that the Company, without notice to or consent of the Holders, may issue additional Securities of this series and thereby increase such principal amount in the future, on the same terms and
conditions (except for issue date, public offering price and, if applicable, the date from which interest accrues and the first Interest Payment Date). Any additional Securities shall be issued under a separate CUSIP number unless: (i) the
additional notes and the outstanding notes of the original series are treated as part of the same “issue” of debt instruments for U.S. Federal income tax purposes, (ii) such additional notes have no more than a de minimis amount of
original issue discount for U.S. federal income tax purposes or (iii) such issuance would constitute a “qualified reopening” for U.S. federal income tax purposes. 

Interest shall be computed on the basis of a 360-day year consisting of twelve 30-day months. The Company shall pay interest on overdue principal, premium, if any, and, to the extent lawful, on overdue installments of interest at the rate per annum borne by this Note. If a payment date is not
a Business Day as defined in the Indenture at a Place of Payment, payment may be made at that place on the next succeeding day that is a Business Day, and no interest shall accrue for the intervening period. 

In case an Event of Default (as defined in the Indenture) with respect to the Notes shall have occurred and be continuing, the principal
hereof and the interest accrued hereon, if any, may be declared, and upon such declaration shall become, due and payable, in the manner, with the effect and subject to the conditions provided in the Indenture. 

The Indenture contains provisions that provide that the Company and the Trustee may enter into an indenture or indentures supplemental hereto
for the purpose of amending any provisions of the Indenture or of modifying in any manner the rights of the Holders of the Securities of such series to be affected with the written consent of the Holders of a majority in

  
 B2-5 

 
principal amount of the Outstanding Securities of such series affected by such amendment voting separately; provided that, without the consent of each Holder of the Securities of each
series affected thereby, an amendment may not: (i) extend the Stated Maturity of the principal of, or any installment of interest on, such Holder’s Security, or reduce the principal amount thereof or the interest thereon or any premium
payable upon redemption thereof, or change the Currency in which the principal of and premium, if any, or interest on such Security is denominated or payable, or reduce the amount of the principal of an Original Issue Discount Security that would be
due and payable upon a declaration of acceleration of the Maturity thereof, or impair the right to institute suit for the enforcement of any payment on or after the Stated Maturity thereof (or, in the case of redemption, on or after the Redemption
Date), or materially adversely affect the economic terms of the Holder’s right to convert or exchange any Security as may be provided in the Indenture; (ii) reduce the percentage in principal amount of the Outstanding Securities of any
series, the consent of whose Holders is required for any supplemental indenture, or the consent of whose Holders is required for any waiver of compliance with certain provisions of the Indenture or certain Defaults hereunder and their consequences
provided for in the Indenture; (iii) modify any of the provisions of the Indenture governing amendments or waivers with the consent of Holders except to increase any such percentage or to provide that certain other provisions of the Indenture
cannot be modified or waived without the consent of the Holder of each Outstanding Security affected thereby; or (iv) modify, without the written consent of the Trustee, the rights, duties or immunities of the Trustee. 

It is also provided in the Indenture that, subject to certain conditions and exceptions, the Holders of a majority in aggregate principal
amount of a series of Securities at the time Outstanding may on behalf of the Holders of all of the Securities of such series waive any past Default or Event of Default hereunder and its consequences except a Default in the payment of interest or
any premium on or the principal of the Securities of such series or a Default in respect of a covenant or provision of the Indenture that cannot be modified or amended without the consent of the Holder of each Outstanding Security of such series.
Upon any such waiver, the Company, the Trustee and the Holders of the Securities of such series shall be restored to their former positions and rights under the Indenture, respectively; provided that no such waiver shall extend to any subsequent or
other Default or Event of Default or impair any right consequent thereon. 
 No reference herein to the Indenture and no provision of this
Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and interest on this Note in the manner, at the place, at the respective times, at the rate and in the coin or
currency herein prescribed. 
 The Notes will be issued in fully registered form without coupons in minimum denominations of $2,000 and
multiples of $1,000 in excess thereof and are transferable and exchangeable at the office or agency of the Company maintained for such purpose, which shall initially be the Corporate Trust Office of the Trustee, and in the manner and subject to the
limitations provided in the Indenture. 
 Upon due presentment for registration of transfer of this Note at the office or agency of the
Company maintained for such purpose, which shall initially be the Corporate Trust 

  
 B2-6 

 
Office of the Trustee, a new Note or Notes of authorized denominations for an equal aggregate principal amount shall be issued to the transferee in exchange therefor, subject to the limitations
provided in the Indenture, without charge except for any tax or other governmental charge imposed in connection therewith. 
 The Company,
the Trustee and any agent of the Company or the Trustee may deem and treat the registered Holder hereof as the absolute owner of this Note (whether or not this Note shall be overdue and notwithstanding any notation of ownership or other writing
hereon), for the purpose of receiving payment of, or on account of, the principal hereof and, subject to the provisions hereof, interest hereon, and for all other purposes, and neither the Company nor the Trustee nor any agent of the Company or the
Trustee shall be affected by any notice to the contrary. 
 No recourse under or upon any obligation, covenant or agreement contained in the
Indenture or any indenture supplemental thereto or in any Note, or because of any indebtedness evidenced thereby, shall be had against any incorporator as such, or against any past, present or future stockholder, officer or director, as such, of the
Company or of any successor, either directly or through the Company or any successor, under any rule of law, statute or constitutional provision or by the enforcement of any assessment or by any penalty or otherwise, all such liability being
expressly waived and released by the acceptance hereof and as part of the consideration for the issue hereof. 
 Terms used herein that are
defined in the Indenture shall have the respective meanings assigned thereto in the Indenture. 
 The laws of the State of New York (without
regard to conflicts of laws principles thereof) shall govern this Note. 
 Optional Redemption 

At any time prior to the Par Call Date (as defined below), the Company shall have the right at its option to redeem the Notes, in whole or from
time to time in part, at a Redemption Price equal to the greater of: 
  

	 	(iii)	100% of the principal amount of the Notes to be redeemed; or 

  

	 	(iv)	the sum of the present values of the remaining scheduled payments of principal and interest on the Notes to be redeemed (exclusive of interest accrued to the Redemption Date) from the Redemption Date to the Par Call
Date, discounted to the Redemption Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at a rate equal to the sum of the applicable
Treasury Rate plus 40 basis points, together with, accrued and unpaid interest on the principal amount of the Notes to be redeemed to, but not including, the Redemption Date. 

At any time on or after the Par Call Date, the Company shall have the right at its option to redeem the Notes, at any time in whole or from
time to time in part, at a 

  
 B2-7 

 
Redemption Price equal to 100% of the principal amount of the Notes to be redeemed, plus, accrued and unpaid interest, if any, on the principal amount of the Notes to be redeemed to, but
excluding, the Redemption Date. 
 For the purposes of determining the Redemption Price, “Treasury Rate” means, with respect to
any Redemption Date, the rate per year equal to: (1) the yield, under the heading which represents the average for the immediately preceding week, appearing in the most recently published statistical release designated “H.15(519)” or
any successor publication which is published weekly by the Board of Governors of the Federal Reserve System and which establishes yields on actively traded United States Treasury securities adjusted to constant maturity under the caption
“Treasury Constant Maturities,” for the maturity corresponding to the applicable Comparable Treasury Issue; provided that, if no maturity is within three months before or after the Remaining Life of the Notes to be redeemed, yields for the
two published maturities most closely corresponding to the applicable Comparable Treasury Issue shall be determined and the Treasury Rate shall be interpolated or extrapolated from those yields on a straight line basis, rounding to the nearest
month; or (2) if such release (or any successor release) is not published during the week preceding the calculation date or does not contain such yields, the rate per year equal to the semiannual equivalent yield to maturity of the applicable
Comparable Treasury Issue, calculated using a price for the applicable Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the related Comparable Treasury Price for such redemption date. The Treasury Rate shall be
calculated on the third business day preceding the redemption date. 
 “Comparable Treasury Issue” means the United States
Treasury security selected by an Independent Investment Banker as having a maturity comparable to the remaining term (“Remaining Life”) of the Notes to be redeemed that would be utilized, at the time of selection and in accordance with
customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of such Notes (assuming, for this purpose, such Notes mature on the Par Call Date). “Independent Investment
Banker” means one of the Reference Treasury Dealers that the Company appoints to act as the Independent Investment Banker from time to time. 

“Comparable Treasury Price” means, with respect to any redemption date, (1) the average of the Reference Treasury Dealer
Quotations for such redemption date, after excluding the highest and lowest Reference Treasury Dealer Quotations, or (2) if the Independent Investment Banker obtains fewer than four such Reference Treasury Dealer Quotations, the average of all
such quotations. 
 “Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and any
redemption date, the average, as determined by the Independent Investment Banker, of the bid and asked prices for the applicable Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the
Independent Investment Banker by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the third business day preceding such redemption date. As used in the immediately preceding sentence and in the definition of “Treasury
Rate” above, the term “business day” means any day that is not a Saturday, Sunday or other day on which commercial banks in New York City 

  
 B2-8 

 
are authorized or obligated by law or executive order to close. “Reference Treasury Dealer” means (1) each of Citibank Global Markets Inc., J.P. Morgan Securities LLC and
Merrill Lynch, Pierce, Fenner & Smith Incorporated and their respective successors, unless any of them ceases to be a primary U.S. Government securities dealer in New York City (a “Primary Treasury Dealer”), in which case the
Company shall substitute another Primary Treasury Dealer and (2) any other Primary Treasury Dealer selected by the Company. 

“Par Call Date” means November 15, 2026. 

Special Mandatory Redemption 
 In the
event the closing of the Proposed Acquisition has not occurred on or prior to the earlier of (i) June 19, 2017 (provided that, if the termination date of the Acquisition Agreement is extended, this date will also be extended to the same
extended termination date, but in no case will this date be extended beyond September 15, 2017) and (ii) the date the Acquisition Agreement is terminated (each, a “Special Mandatory Redemption Event”), the Company shall redeem
the Notes in whole at a special mandatory redemption price (the “Special Mandatory Redemption Price”) equal to 101% of the aggregate principal amount of the Notes, plus accrued and unpaid interest on the principal amount of the Notes to,
but not including, the Special Mandatory Redemption Date (as defined below). Upon the occurrence of a Special Mandatory Redemption Event, the Company shall promptly (but in no event later than 10 Business Days following such Special Mandatory
Redemption Event) cause notice to be delivered electronically or mailed, with a copy to the Trustee, to each holder at its registered address (such date of notification to the holders, the “Redemption Notice Date”). The notice will inform
holders that the Notes will be redeemed on the 30th day (or if such day is not a Business Day, the first Business Day thereafter) following the Redemption Notice Date (such date, the “Special Mandatory Redemption Date”) and that all of the
outstanding Notes will be redeemed at the Special Mandatory Redemption Price on the Special Mandatory Redemption Date automatically and without any further action by the holders of the Notes. At or prior to 12:00 p.m., New York City time, on the
Business Day immediately preceding the Special Mandatory Redemption Date, the Company shall deposit with the Trustee funds sufficient to pay the Special Mandatory Redemption Price for the Notes. If such deposit is made as provided above, the Notes
will cease to bear interest on and after the Special Mandatory Redemption Date. There is no escrow account for, or security interest in, the proceeds of the offering for the benefit of the holders of the Notes. 

For purposes of the immediately preceding paragraph, the following terms have the following definitions: 

“Acquisition Agreement” means the interest purchase agreement signed September 19, 2016 between the Company and Avnet Inc. to
acquire all the shares of AVT Technology Solutions LLC and TS Divestco B.V., which will hold all assets and liabilities primarily relating to the technology solutions business of Avnet Inc. 

“Proposed Acquisition” means the proposed acquisition by the Company of all the shares of AVT Technology Solutions LLC and TS
Divestco B.V., which will hold all assets and liabilities primarily relating to the technology solutions business of Avnet Inc., pursuant to the Acquisition Agreement. 

  
 B2-9 

 Interest Rate Adjustment 

The annual interest rate payable on the Notes shall be subject to adjustment from time to time if either Moody’s or S&P (each as
defined in “—Change of Control Offer” below) or, if applicable, any “nationally recognized statistical rating organization” within the meaning of Section 3(a)(62) of the Exchange Act selected by the Company (as certified by
a resolution of the Company’s board of directors) as a replacement for Moody’s or S&P, as the case may be, (each, a “Substitute Rating Agency”), downgrades (or downgrades and subsequently upgrades) the credit rating assigned
to the Notes, in the manner described below. Each of Moody’s, S&P and any Substitute Rating Agency is an “Interest Rate Rating Agency,” and together they are “Interest Rate Rating Agencies.” 

If the rating assigned by Moody’s (or, if applicable, any Substitute Rating Agency) of the Notes is decreased to a rating set forth in
the immediately following table, the interest rate on the Notes shall increase such that it shall equal the interest rate payable on the Notes on the date of their initial issuance plus the percentage set forth opposite the rating in the table below
(plus, if applicable, the percentage set forth opposite the rating in the table under “—S&P Rating”): 
  

			
	 Moody’s* Rating:
	  	Interest Rate Increase:
	 Ba1
	  	0.25%
	 Ba2
	  	0.50%
	 Ba3
	  	0.75%
	 B1 or below
	  	1.00%

  

	*	Including the equivalent ratings of any Substitute Rating Agency. 

 If the rating assigned by
Moody’s (or, if applicable, any Substitute Rating Agency) of the Notes is decreased to a rating set forth in the immediately following table, the interest rate on the Notes shall increase such that it shall equal the interest rate payable on
the Notes on the date of their initial issuance plus the percentage set forth opposite the rating in the table below (plus, if applicable, the percentage set forth opposite the rating in the table under “—Moody’s Rating”): 

 

			
	 S&P Rating*:
	  	Interest Rate Increase:
	 BB+
	  	0.25%
	 BB
	  	0.50%
	 BB-
	  	0.75%
	 B+ or below
	  	1.00%

  

	*	Including the equivalent ratings of any Substitute Rating Agency. 

 If at any time the interest
rate on the Notes has been increased and any of the Interest Rate Rating Agencies subsequently upgrades its rating of the Notes, the interest rate on the Notes shall be decreased such that the interest rate for the Notes equals the interest rate
payable on the Notes on the date of their initial issuance plus the percentages set forth opposite 

  
 B2-10 

 
the ratings from the tables above in effect immediately following the upgrade in rating. If Moody’s (or any Substitute Rating Agency) subsequently upgrades its rating of the Notes to Baa3
(or its equivalent, in the case of a Substitute Rating Agency) or higher, and S&P (or any Substitute Rating Agency) upgrades its rating to BBB- (or its equivalent, in the case of a Substitute Rating
Agency) or higher, the interest rate on the Notes shall be decreased to the interest rate payable on the Notes on the date of their initial issuance (and if one such upgrade occurs and the other does not, the interest rate on the Notes shall be
decreased so that it does not reflect any increase attributable to the upgrading Interest Rate Rating Agency). In addition, the interest rates on the Notes shall permanently cease to be subject to any adjustment described above (notwithstanding any
subsequent downgrade in the ratings by any of the Interest Rate Rating Agencies) if the Notes become rated Baa1 and BBB+ (or, in either case, the equivalent thereof, in the case of a Substitute Rating Agency) or higher by Moody’s and S&P
(or, in either case, any Substitute Rating Agency), respectively (or one of these ratings if the Notes are only rated by one rating agency). 

Each adjustment required by any downgrade or upgrade in a rating set forth above, whether occasioned by the action of Moody’s or S&P
(or, in either case, any Substitute Rating Agency), shall be made independent of any and all other adjustments. In no event shall (1) the interest rate on the Notes be reduced to below the interest rate payable on the Notes on the date of their
initial issuance or (2) the total increase in the interest rate on the Notes exceed 2.00% above the interest rate payable on the Notes on the date of their initial issuance. 

No adjustments in the interest rate of the Notes shall be made solely as a result of an Interest Rate Rating Agency ceasing to provide a
rating on the Notes. If at any time less than two Interest Rate Rating Agencies provide a rating of the Notes for reasons beyond the Company’s control, the Company shall use its commercially reasonable efforts to obtain a rating of the Notes
from a Substitute Rating Agency, if one exists, in which case, for purposes of determining any increase or decrease in the interest rate on the Notes pursuant to the tables above (a) such Substitute Rating Agency shall be substituted for the
last Interest Rate Rating Agency to provide a rating of the Notes but which has since ceased to provide such rating, (b) the relative rating scale used by such Substitute Rating Agency to assign ratings to senior unsecured debt shall be
determined in good faith by an independent investment banking institution of national standing appointed by the Company and, for purposes of determining the applicable ratings included in the applicable table above with respect to such Substitute
Rating Agency, such ratings shall be deemed to be the equivalent ratings used by Moody’s or S&P, as applicable, in such table and (c) the interest rate on the Notes shall increase or decrease, as the case may be, such that the interest
rate equals the interest rate payable on the Notes on the date of their initial issuance plus the appropriate percentage, if any, set forth opposite the deemed equivalent rating from such Substitute Rating Agency in the applicable table above
(taking into account the provisions of clause (b) above) (plus any applicable percentage resulting from a decreased rating by the other Interest Rate Rating Agency). 

For so long as only one Interest Rate Rating Agency provides a rating of the Notes, any subsequent increase or decrease in the interest rate
of the Notes necessitated by a reduction or increase in the rating by the Interest Rate Rating Agency providing the rating shall be twice the applicable percentage set forth in the applicable table above. For so long as no

  
 B2-11 

 
Interest Rate Rating Agency provides a rating of the Notes, the interest rate on the Notes shall increase to, or remain at, as the case may be, 2.00% above the interest rate payable on the Notes
on the date of their initial issuance. 
 Any interest rate increase or decrease described above shall take effect from the first day of the
interest period commencing after the date on which a rating change occurs that requires an adjustment in the interest rate. If any Interest Rate Rating Agency changes its rating of the Notes more than once prior to any particular Interest Payment
Date, the last change by such agency prior to such Interest Payment Date shall control for purposes of any interest rate increase or decrease with respect to the Notes described above relating to such rating agency’s action. If the interest
rate payable on the Notes is increased as described above, the term “interest,” as used with respect to the Notes, shall be deemed to include any such additional interest unless the context otherwise requires. 

Change of Control Offer 
 If a Change of
Control Triggering Event (as defined below) occurs, unless the Company has exercised its right to redeem the Notes as provided under the Optional Redemption described above, the Company shall be required to make an offer to each Holder of Notes to
purchase all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of that Holder’s Notes at a purchase price in cash equal to 101% of the aggregate principal amount thereof, plus accrued and unpaid interest, if any,
to, but not including, the date of purchase (subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment date); provided that after giving effect to the purchase, any Notes that
remain outstanding shall have a denomination of $2,000 and integral multiples of $1,000 above that amount. 
 Within 30 days following the
date upon which the Change of Control Triggering Event has occurred or, at the Company’s option, prior to any Change of Control (as defined below) but after the public announcement of the transaction that constitutes or may constitute the
Change of Control, except to the extent that the Company has exercised its right to redeem the Notes as provided under the Optional Redemption described above, the Company shall mail a notice (a “Change of Control Offer”) to each Holder
with a copy to the Trustee describing the transaction or transactions that constitute or may constitute a Change of Control Triggering Event and offering to purchase Notes on the date specified in the notice, which date shall be no earlier than 30
days nor later than 60 days from the date such notice is delivered (other than as may be required by law) (such date, the “Change of Control Payment Date”). The notice shall, if delivered prior to the date of consummation of the Change of
Control, state that the Change of Control Offer is conditioned on the Change of Control being consummated on or prior to the Change of Control Payment Date. 

On the Change of Control Payment Date, the Company shall, to the extent lawful (a) accept for payment all Notes or portions of the Notes
properly tendered pursuant to the Change of Control Offer; (b) deposit with the Paying Agent an amount equal to the change of control payment in respect of all Notes or portions of Notes properly tendered pursuant to the Change of Control
Offer; and (c) deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers’ Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. 

  
 B2-12 

 The Company shall comply, to the extent applicable, with the requirements of Rule 14(e)-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and any other securities laws or regulations in connection with the purchase of Notes pursuant to a Change of Control
Triggering Event. To the extent that the provisions of any securities laws or regulations conflict with the terms described in the Notes, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to have
breached its obligations by virtue thereof. 
 Holders of Notes electing to have Notes purchased pursuant to a Change of Control Offer shall
be required to surrender their Notes, with the form entitled “Option of Holder to Elect Purchase” attached hereto completed, to the Paying Agent at the address specified in the notice, or transfer their Notes to the Paying Agent by
book-entry transfer pursuant to the applicable procedures of the Paying Agent, prior to the close of business on the third business day prior to the Change of Control Payment Date. 

The Company shall not be required to make a Change of Control Offer if a third party makes such an offer in the manner, at the times and
otherwise in compliance with the requirements for an offer made by the Company and such third party purchases all Notes properly tendered and not withdrawn under its offer. 

If Holders of not less than 95% in aggregate principal amount of the outstanding Notes validly tender and do not withdraw such Notes in a
Change of Control Offer and the Company, or any third party making a Change of Control Offer in lieu of the Company, as described above, purchases all of the Notes validly tendered and not withdrawn by such Holders, the Company shall have the right,
upon not less than 30 nor more than 60 days’ prior notice, given not more than 30 days following such purchase pursuant to the Change of Control Offer described above, to redeem all Notes that remain outstanding following such purchase at a
redemption price in cash equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to the Redemption Date (subject to the right of Holders of record on a record date to receive interest on the relevant Interest Payment
Date). 
 For purposes of the Change of Control Offer provisions, the following definitions are applicable: 

“Change of Control” means the occurrence of any one of the following: (a) the direct or indirect sale, lease, transfer,
conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the Company’s assets and the assets of its subsidiaries taken as a whole to any
“person” (as that term is used in Section 13(d)(3) of the Exchange Act) other than to the Company or one of its Subsidiaries; (b) the consummation of any transaction (including without limitation, any merger or consolidation) the
result of which is that any “person” (as that term is used in Section 13(d)(3) of the Exchange Act) becomes the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the Company’s outstanding Voting Stock, measured by voting power rather than number of shares; (c) the Company

  
 B2-13 

 
consolidates with, or merges with or into, any person, or any person consolidates with, or merges with or into, the Company, in any such event pursuant to a transaction in which any of the
Company’s outstanding Voting Stock or the outstanding Voting Stock of such other person is converted into or exchanged for cash, securities or other property, other than any such transaction where the shares of the Company’s Voting Stock
outstanding immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Stock of the surviving person immediately after giving effect to such transaction; (d) the first day on which the
majority of the members of the Company’s board of directors cease to be Continuing Directors; or (e) the adoption of a plan relating to the Company’s liquidation or dissolution. 

“Change of Control Triggering Event” means the occurrence of both a Change of Control and a Ratings Event. 

“Continuing Director” means, as of any date of determination, any member of the Company’s board of directors who (a) was a
member of such board of directors on January 24, 2017 or (b) was nominated for election, elected or appointed to the Company’s board of directors with the approval of a majority of the continuing directors who were members of the
Company’s board of directors at the time of such nomination, election or appointment (either by a specific vote or by approval of the Company’s proxy statement in which such member was named as a nominee for election as a director, without
objection to such nomination). 
 “Investment Grade” means a rating of Baa3 or better by Moody’s (or its equivalent under any
successor rating category of Moody’s); a rating of BBB- or better by S&P (or its equivalent under any successor rating category of S&P); and the equivalent investment grade rating from any
replacement Rating Agency or Agencies appointed by the Company. 
 “Moody’s” means Moody’s Investors Service, Inc., a
subsidiary of Moody’s Corporation, and its successors. 
 “Rating Agency” means each of Moody’s and S&P; provided
that, if either of Moody’s or S&P ceases to rate the Notes or fails to make a rating of the Notes publicly available, the Company shall appoint a replacement for such Rating Agency that is a “nationally recognized statistical rating
organization” within the meaning of Section 3(a)(62) under the Exchange Act. 
 “Ratings Event” means ratings of the Notes
are lowered by each of the Rating Agencies and the Notes rated below Investment Grade by each of the Rating Agencies in any case on any day during the period (the “Trigger Period”) commencing on the date 60 days prior to the first public
announcement by the Company of any Change of Control (or pending Change of Control) and ending 60 days following consummation of such Change of Control (which Trigger Period shall be extended for so long as the rating of the Notes is under publicly
announced consideration for a possible downgrade by either of the Rating Agencies). 
 “S&P” means Global Ratings, a division
of S&P Global, Inc., and its successors. 

  
 B2-14 

 “Voting Stock” of any specified person as of any date means the Capital Stock of such
person that is at the time entitled to vote generally in the election of the board of directors of such person. 
 Restrictive Covenants 

        Restrictions on Liens. 

The Company shall not, and shall not permit any Restricted Subsidiary to, create or incur any Lien on any shares of stock of a Restricted
Subsidiary or Principal Property of the Company or of a Restricted Subsidiary, whether those shares of stock of a Restricted Subsidiary or Principal Property are owned at the date hereof or acquired afterwards, unless the Company secures or causes
the applicable Restricted Subsidiary to secure the debt securities outstanding under the Indenture (together with any other indebtedness or other obligations the terms of which (or the terms of any agreement evidencing or relating to which) require
that such indebtedness be so secured) equally and ratably with (or, at the Company’s option, prior to) all indebtedness secured by the particular Lien, so long as the indebtedness is so secured. 

This covenant does not apply in the case of: (a) the creation of any Lien on any shares of stock of a Subsidiary or any Principal
Property acquired after the date hereof (including acquisitions by way of merger or consolidation) by the Company or a Restricted Subsidiary, contemporaneously with that acquisition, or within 180 days thereafter, to secure or provide for the
payment or financing of any part of the purchase price, or the assumption of any Lien upon any shares of stock of a Subsidiary or any Principal Property acquired after the date hereof existing at the time of the acquisition, or the acquisition of
any shares of stock of a Subsidiary or any Principal Property subject to any Lien without the assumption of that Lien, provided that every Lien referred to in this clause (a) will attach only to the shares of stock of a Subsidiary or any
Principal Property so acquired and fixed improvements on that Principal Property; (b) any Lien on any shares of stock of a Subsidiary or any Principal Property existing on the date hereof; (c) any Lien on any shares of stock of a
Subsidiary or any Principal Property in favor of the Company or any Restricted Subsidiary; (d) any Lien on any Principal Property being constructed or improved securing loans to finance the construction or improvements of that property;
(e) any Lien created by a lease of any Principal Property, which under GAAP as in effect as of the date hereof would be characterized as an operating lease, whether entered into before or after the date hereof, including Liens arising under or
in connection with (i) the Synthetic Lease Facility or any refinancing, renewal or restructuring of the Synthetic Lease Facility; and (ii) any remarketing or purchase by the Company of, or any other action taken by the Company with respect
to, any Principal Property subject to the Synthetic Lease or any refinancing, renewal or restructuring thereof to the extent permitted thereby; (f) any Lien on shares of stock of a Subsidiary or any Principal Property incurred in connection
with the issuance of tax-exempt governmental obligations, including, without limitation, industrial revenue bonds and similar financings; (g) any mechanics’, materialmen’s, carriers’ or
other similar Liens arising in the ordinary course of business with respect to obligations that are not yet due or that are being contested in good faith; (h) any Lien on any shares of stock of a Subsidiary or any Principal Property for taxes,
assessments or governmental charges or levies not yet delinquent, or already delinquent but the validity of which is being contested in good faith; (i) any Lien on any Principal Property arising

  
 B2-15 

 
in connection with legal proceedings being contested in good faith, including any judgment Lien so long as execution on the Lien is stayed; (j) any landlord’s Lien on fixtures located
on premises leased by the Company or a Restricted Subsidiary in the ordinary course of business, and tenants’ rights under leases, easements and similar Liens not materially impairing the use or value of the property involved; and (k) any
renewal or extension of or substitution for any Lien permitted by any of the preceding clauses, provided that, in the case of a Lien permitted under clauses (a), (b) or (d), the indebtedness secured is not increased nor the Lien extended to any
additional assets. 
 Notwithstanding the restrictions set forth above, the Company or any Restricted Subsidiary may create or assume Liens
in addition to those permitted by the preceding paragraph, and renew, extend or replace those Liens, provided that at the time of and after giving effect to the creation, assumption, renewal, extension or replacement, Exempted Debt does not exceed
15% of Consolidated Net Tangible Assets of the Company. 
         Restrictions on Sale and
Leaseback Transactions involving Principal Properties. 
 The Company shall not, and shall not permit any Restricted Subsidiary to, sell
or transfer, directly or indirectly, except to the Company or to a Restricted Subsidiary, any Principal Property as an entirety, or any substantial portion of the Company’s Principal Property, with the intention of taking back a lease of such
Principal Property, except a lease for a period of three years or less at the end of which it is intended that the use of that Principal Property by the lessee will be discontinued. Notwithstanding the foregoing, the Company or any Restricted
Subsidiary may sell any Principal Property and lease it back for a longer period: (a) if such Principal Property is subject to the Synthetic Lease Facility or any refinancing, renewal or restructuring thereof; (b) if the Company or such
applicable Restricted Subsidiary would be entitled pursuant to the Restrictions on Liens described above to create a Lien on the Principal Property to be leased securing Funded Debt in an amount equal to the Attributable Debt with respect to the
sale and lease-back transaction without equally and ratably securing the outstanding Notes; or (c) if the Company promptly informs the Trustee of the transaction, and the Company causes an amount equal to the fair value (as determined by
resolution of its Board of Directors) of the Principal Property to be applied (1) to the purchase of other property that will constitute Principal Property having a fair value at least equal to the fair value of the Principal Property sold, or
(2) to the retirement within 120 days after receipt of the proceeds of Funded Debt incurred or assumed by the Company or a Restricted Subsidiary, including the Notes; provided further that, in lieu of applying all of or any part of such net
proceeds to such retirement, the Company may, within 75 days after the sale, deliver or cause to be delivered to the applicable trustee for cancellation debt securities evidencing Funded Debt of the Company (which may include the Notes) or of a
Restricted Subsidiary previously authenticated and delivered by the applicable trustee, and not yet tendered for sinking fund purposes or called for a sinking fund or otherwise applied as a credit against an obligation to redeem or retire such debt
securities, and an Officer’s Certificate (which will be delivered to the applicable trustee) stating that the Company elects to deliver or cause to be delivered the debt securities in lieu of retiring Funded Debt as provided in this provision.

  
 B2-16 

 If the Company delivers debt securities to the applicable trustee and the Company duly delivers
the Officer’s Certificate pursuant the preceding paragraph, the amount of cash that the Company shall be required to apply to the retirement of Funded Debt under this provision shall be reduced by an amount equal to the aggregate of the then
applicable optional redemption prices (not including any optional sinking fund redemption prices) of the applicable debt securities so delivered or, if there are no such redemption prices, the principal amount of those debt securities. If the
applicable debt securities provide for an amount less than the principal amount to be due and payable upon a declaration of the maturity, then the amount of cash shall be reduced by the amount of principal of those debt securities that would be due
and payable as of the date of the application upon a declaration of acceleration of the maturity pursuant to the terms of the Indenture pursuant to which those debt securities were issued. 

Notwithstanding the foregoing, the Company or any Restricted Subsidiary may enter into sale and lease-back transactions involving any
Principal Property in addition to those permitted under the Restrictions on Liens described above, without any obligation to retire any outstanding Notes or other Funded Debt; provided that at the time of entering into and giving effect to such sale
and lease-back transactions, Exempted Debt does not exceed 15% of Consolidated Net Tangible Assets of the Company. 
 For the purposes of
the foregoing restrictive covenants, the following definitions are applicable: 
 “Attributable Debt” means, as to any particular
lease, the greater of (a) the fair market value of the property subject to the lease or (b) the total net amount of rent required to be paid during the remaining term of the lease, discounted by the weighted average effective interest cost
per annum of the outstanding debt securities of all series, compounded semi-annually. 
 “Consolidated Net Tangible Assets” means
total assets after deducting all current liabilities and intangible assets as set forth in the Company’s most recent consolidated balance sheet and computed in accordance with GAAP. 

“Exempted Debt” means the sum, without duplication, of the following items outstanding as of the date Exempted Debt is being
determined (a) indebtedness of the Company and its Restricted Subsidiaries incurred after the date hereof and secured by Liens created or assumed or permitted to exist pursuant to the Restrictions on Liens described above; and(b) Attributable
Debt of the Company and its Restricted Subsidiaries in respect of all sale and lease-back transactions with regard to any Principal Property entered into pursuant to the last paragraph of the Restrictions on Sale and Leaseback Transactions Involving
Principal Properties described above. 
 “Funded Debt” means all indebtedness for money borrowed, including purchase money
indebtedness, having a maturity of more than one year from the date of its creation or having a maturity of less than one year but by its terms being renewable or extendible at the option of the obligor, beyond one year from the date of its
creation. 

  
 B2-17 

 “GAAP” means generally accepted accounting principles in the United States at the date
of any computation. 
 “Holder” or “Securityholder” mean the registered holder of any debt security with respect to
registered securities and the bearer of any unregistered security or any coupon appertaining to it, as the case may be. 
 “Lien”
means, with respect to any asset, any mortgage, lien, pledge, charge, security interest or encumbrance of any kind, or any other type of preferential arrangement that has the practical effect of creating a security interest in respect of such asset.
For the purposes of this Indenture, the Company or any Subsidiary shall be deemed to own, subject to a Lien, any asset that the Company has acquired or holds subject to the interest of a vendor or lessor under any conditional sale agreement, capital
lease or other title retention agreement relating to such asset. 
 “Principal Property” means the Company’s corporate
headquarters and any warehouse or distribution center, together with any land, land improvements, buildings and fixtures related thereto, owned or leased at the date hereof or acquired after that date by the Company or any of its Restricted
Subsidiaries and which is located within the United States, other than: (a) any property which in the opinion of the Company’s Board of Directors is not of material importance to the total business conducted by the Company as an entirety
or (b) any portion of a particular property which is similarly found not to be of material importance to the use or operation of such property. 

“Restricted Subsidiary” means a Subsidiary of the Company (a) of which substantially all the property is located, or
substantially all the business is carried on, within the United States; and (b) which owns a Principal Property. 
 “Synthetic
Lease Facility” means the Fourth Amended and Restated Lease Agreement, dated as of June 27, 2013, between the Company, as lessee, and SunTrust Bank, as lessor, and each Operative Agreement (as defined therein). 

  
 B2-18 

 ASSIGNMENT 

FOR VALUE RECEIVED, the undersigned hereby sell(s), assign(s) and transfer(s) unto 

[PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE] 
  

 
  

 
 [PLEASE PRINT OR TYPE NAME AND ADDRESS, INCLUDING ZIP
CODE, OF ASSIGNEE] 
  
  

the within Note and all rights thereunder, hereby irrevocably constituting and appointing
                                         
                                Attorney to transfer such Note on the books of the Issuer,
with full power of substitution in the premises. 
  

									
		 		 		 		 	     Signature:
	  
 Dated:
	 	  

                        

	 		 		 	  

		 		 		 		 	NOTICE: The signature to this assignment must correspond with the name as written upon the face of the within Note in every particular without alteration or enlargement or any change whatsoever.

  
 B2-19 

 SIGNATURE GUARANTEE 

[Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar, which requirements
include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for, STAMP, all
in accordance with the Securities Exchange Act of 1934, as amended.] 

  
 B2-20 

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Note purchased by the Company pursuant to a Change of Control Offer, check the box below: 

 
 ☐ 

If you want to elect to have only part of the Note purchased by the Company pursuant to a Change of Control Offer, state the amount you elect
to have purchased: $________ 
 Date:____________________ 
  

			
	 Your Signature:     
	 	                                     
                               
		 	  

(Sign exactly as your name appears on the face of this Note)

		
	 Tax Identification No.:
	 	                                     
                               
		
	 Signature Guarantee:
	 	                                     
                               

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the
Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in
substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 

  
 B2-21 

 SCHEDULE OF INCREASES OR DECREASES IN NOTE 

The initial principal amount of this Note is $500,000,000. The following increases or decreases in a part of this Note have been made: 

 

									
	 Date
	  	 Amount of

decrease in

principal

amount of this

Note
	  	 Amount of

increase in

principal

amount of this

Note
	  	 Principal

amount of this

Note following

such decrease

(or increase)
	  	 Signature of

authorized

signatory of

Trustee

		  		  		  		  	

  
 B2-22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}]]